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ABSTRACT 
Microorganisms have evolved to exist in diverse environments on earth, even under 
the harsh conditions of oil reservoirs several kilometres below the seafloor. The 
environmental conditions there are extreme in several aspects, such as high 
temperature, pressure, salinity, and presence heavy metals or other potentially toxic 
compounds. In order to live under these conditions, the microbes’ enzymes have 
evolved to withstand the extremes. Enzymes with such traits might be utilized for 
several biochemical industries. 
In a previous project, microbial DNA from two oil reservoirs has been isolated and 
high-throughput pyrosequencing used to create an extensive metagenomic DNA 
sequence database. Using bioinformatics tools, three putative gene sequences for 
thermostable peptidases were identified in this oil reservoir metagenomic sequence 
database. They showed a high degree of sequence homology to a known peptidase 
of the enzyme sub-classes, subtilisin-like protease, carboxypeptidase or 
aminopeptidases, and were named SLP01, CPT01 and ATP01. 
Protein production of the recombinant proteins was performed in Escherichia coli 
strains BL21 (DE3) CodonPlus-RIPL and ER2566, using the plasmid vector pET21, at 
temperatures 16 and 37 °C. Desired protein production was verified using SDS-PAGE 
analysis. Production of target protein was observed for the APT01 and CPT01 
candidate, although in an insoluble form. Some soluble APT01 was observed when 
the culture had been incubated at 16 °C.  
Heat denaturation series was performed on the sample containing soluble APT01, at 
temperatures of 65 and 80 °C for a duration of 5, 15, 30, 60 and 120 minutes. The 
results showed APT01 to be thermostable at 65 °C, but none at 80 °C. An activity 
assay, using skim milk agar (MA) plates, was performed on all samples from the protein 
production. No activity was observed for any of the three candidates. 
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1. INTRODUCTION 
1.1 Microbial diversity and bioprospecting  
Microbes have been found to live in most of earths extreme environments, from 
hydrothermal vents in the deep-sea to the dry valleys of Antarctica. These 
microorganisms are called extremophiles, or poly-extremophiles if they thrive in (or 
tolerate1) an environment that is extreme for more than one condition (Rothschild, 
2001). These extremes can be high or low temperatures and pH, high salinity or 
pressure, or the presence of toxic or degenerative compounds (e.g. high concentration 
of heavy metal ions and organic solvents). In order to live and multiply under such 
conditions these microbes have adapted their metabolism to tolerate the extremes.  
There is an increasing demand within modern biotechnology to discover among others 
new antibiotics and novel biocatalysts for use in biocatalytic industrial processes. By 
finding enzymes that can catalyse a desired reaction at high temperature or pressure, 
new and more efficient processes for productions of products such as 
pharmaceuticals, agrochemicals and food additives can be obtained. Cultivation and 
isolation of strains containing the desired characteristics by assays have traditionally 
been used to discover novel enzymes. However, of the microbes present in several 
environments, as much as 99.8% cannot be grown readily in pure culture and therefore 
cannot be exploited for biotechnology in a traditional manner (Streit, 2004). The 
“metagenome technology” provides an alternative approach, by allowing cloning of 
environmental DNA, screening for desired function and production of protein of interest 
without cultivation of the original organism. So far, metagenomic analysis have been 
used to find novel antibiotics and antibiotic resistance genes, lipases, amylases, 
deoxyribonuclease and lyases, to mention some (Lewin, 2013, Rondon, 2000). 
Metagenomic research is important, not only to identify novel enzymes and bioactive 
compounds, but also to obtain a greater understanding of the vast uncultivable 
microbial diversity that exists. To analyse the microbial community as a whole and try 
to understand the underlying metabolic mechanisms and regulatory network making 
these communities function. With the current technology it is now possible to gain a 
further and more complete understanding of the evolution of these microbes, and how 
                                                          
1 For simplicity the term extremophile is not only used for the microbes that “phile” (ie. love) the 
environment, but also for organisms that tolerate and are able to live under these condition. 
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they have adapted to live under such poly-extreme conditions (Handelsman, 2004, 
Lewin, 2013).   
 
1.1.1 Metagenomic libraries  
Metagenomics research is the analysis of genomic DNA directly isolated from an 
environment. DNA libraries are made using isolated DNA from environmental samples, 
either by use of cloning vectors or by direct sequencing (figure 1.1). To make a clone 
library, isolated metagenomic DNA is digested and inserted into plasmids, for small 
inserts (<10 kb), or cosmids, fosmids or bacterial artificial chromosomes (BACs) for 
larger inserts (>20 kb). Host cells are then transformed with the vector and 16S DNA 
from each clone is amplified, purified and sequenced using, for instance, Sanger 
sequencing (Rondon, 2000, Sabree, 2009). A much faster way of making a 
metagenomic DNA sequence library is by direct sequencing, using next generation 
sequencing technologies. Commercial pyrosequencing for metagenomic research was 
developed by the company 454 Life Sciences, so ‘454 sequencing’ is a much-used 
method for making direct sequence libraries. Sequence reads from the 
pyrosequencing is finally assembled into contigs, which comprises the DNA library 
(Kotlar, 2011, Lewin, 2013, Petrosino, 2009).    
Metagenomic libraries can be made based on samples from environments never 
before been analysed, or environments where only a small fraction of the total microbial 
diversity have been analysed in the past. There are two main strategies to identify 
genes of interest in metagenomic libraries. The first being function-based analysis, the 
other using sequence-based searches, each having their strengths and limitations. 
Using these methods, it allows us to tap into the nearly unlimited resource of novel 
genes for enzymes and other compounds that potentially can be utilized in the field of 
medicine (e.g. antibiotics) or as biocatalysts to streamline industrial bioprocesses. 
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Figure 1.1: Schematic overview of metagenomic study methodology and construction of DNA libraries from 
environmental samples (a-j)(Lewin, 2012). 
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1.1.2 Function-based analysis 
For function-based screening, cloned metagenomic libraries are constructed and 
expressed in a suitable host organism. The screening process to identify clones with 
the desired trait is often done by relatively ‘simple’ activity assays. Identifying clones 
that express a certain characteristic is independent to sequence homology, which 
makes it the only approach that can potentially identify entirely new gene classes 
(Handelsman, 2004). The downside of this strategy is the heterologous expression and 
low detection frequencies of functional proteins. For example, in a study done by 
Rondon et al. in 1999 only 29  hemolytically active clones where identified out of a total 
of over 28 000 clones (Rondon, 2000). In the search for florfenicol2 resistance genes 
from Alaskan soil, only a single clone was identified from 13 201 Mb of DNA screened 
(Lang, 2010). Reasons for this can be found all along the protein synthesis pathway, 
from inefficient transcription and translation of the metagenomic gene, insufficient 
secretion of the foreign protein, incorrect folding, or lack of cofactors necessary for the 
proteins stability and activity (Streit, 2004). The protein product can also be toxic to the 
host cell at different levels. When expressed under control of a strong promoter the 
over-expression of the recombinant gene can lead to depletion of the cells energy 
stores causing the growth rate to stall or, in worst case, kill the organism (Tabor, 2001). 
 
1.1.3 Sequence-based Analysis 
Gene mining, direct PCR and hybridization are tools that are used for sequence-based 
analysis. For gene mining, algorithms and bioinformatics tools are used to search for 
sequence alignments between the metagenomic DNA library and annotated 
sequences of interest in a database (e.g. UniProt). Sequence alignment analyses can 
be performed on any computer with access to the metagenomic DNA library of interest 
and a protein database (many are available online). This makes this a cheap and 
effective approach in the search for DNA sequences of interest. PCR and hybridization 
techniques include the use of arrays and metagenome sequence tags (MSTs) to 
identify conserved regions of genes. All sequence-based screening is based on 
conserved and know sequences and cannot be used to detect new gene classes 
(Streit, 2004). Another limitation of the homology-based identification is that the 
                                                          
2 Florfenicol is a synthetic fluorinated derivative of chloramphenicol. 
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functionality of detected putative genes must be demonstrated, which faces the same 
challenges of recombinant gene expression as described for the function-based 
analysis. Despite this, it is anticipated that combined with the improvement of 
bioinformatics tools and protein classification, sequence-based screening of 
metagenomic databases will have a greater influence on identifying novel biocatalysts 
compered to function-based analysis (Li, 2009). 
The Basic Local Alignment Search Tool (BLAST) is one of the bioinformatic tools used 
for sequence-based screening of metagenomic DNA libraries (Altschul, 1997). It is a 
widely used tool to find regions of local similarities between protein or DNA sequences, 
using annotated databases. BLAST can be used to help identify gene families and to 
deduce functional and evolutionary relationship between sequences. Different BLAST 
programs allow you to search a nucleotide, translated nucleotide or protein database 
using a nucleotide, translated nucleotide or protein sequence as query. The query is 
compared to sequences in the chosen database and statistical significance of the 
matches is calculated and displayed. A second much used bioinformatic tool for 
sequence-based screening is the Open reading Frame (ORF) Finder. This program 
identifies the possible open reading frames in the DNA sequence query, and lists these 
along with their protein translation. Information provided by these two tools can be used 
to identify putative genes interest, for instance genes encoding novel biocatalysts. To 
increase the chance of identifying an active gene which encodes a functional protein, 
the DNA sequence need to contain elements such as a start and stop codon and 
Shine-Dalgarno sequence, used by the cells transcriptional machinery to initiate and 
terminate gene expression. The encoded protein sequence should contain a 
conserved active site, which can be checked using BLAST to compare the protein 
sequence given by ORF Finder to a protein database.  
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1.1.4 Oil Reservoir Microbiology and Metagenomics  
Within the first years of the metagenomic era the main focus has been on easily 
accessible environmental samples, such as soil (Rondon, 2000) (Lang, 2010), while 
more extreme environments like hot springs, glacial ice or marine subsurface have 
remained an untapped source of potentially valuable biocatalysts. Biddle and 
co-workers (2008) wrote that “The subseafloor marine biosphere may be one of the 
largest reservoirs of microbial biomass on Earth […].” (Biddle, 2008). Deep subsurface 
oil reservoirs are an example of poly-extreme environments of the subseafloor. These 
are environments with high temperature, pressure and salinity, and they have often 
been physically separated to life on the surface for a very long time. The formation of 
oil utilizes organic material deposited millions of years ago. The microorganisms 
associated with this material might therefore have been separated from the surface 
environment for a substantial amount of time, indicating a difference to their relatives 
on the surface at the DNA sequence level (Kotlar, 2011). 
This project is part of an ongoing research activity started in 2008 as a collaboration 
between SINTEF, NTNU and Statoil. Two samples, one from each of two separate oil 
reservoir wells on the Norwegian Continental Shelf (NCS) (figure 1.2), were collected 
using specialized technology allowing contamination-free samples, as well as avoiding 
potential loss of microbes DNA due to rapid pressure changes. Total DNA of the 
samples was isolated and direct 454 pyrosequencing was used to construct 
metagenomic DNA libraries. Bioinformatics analysis on the DNA sequences showed 
that the reservoirs harbour a rich community of microorganism, but are dominated by 
a smaller number of taxa (Kotlar, 2011). Bacteria dominate “Well I” with a smaller 
fraction of Archaea, while it is the opposite for “Well II”. However, the two wells appear 
to contain essentially the same organisms. Considering that the two reservoirs appear 
to be physically separate, and that they have been separated for a considerable 
amount of time, Lewin and coworkers (2013) proposed that the average generation 
times of the organisms are extremely long resulting in a small degree of evolvement 
since the separation took place. 
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Figure 1.2: “Schematic representation of the geological profile of the area for oil reservoir wells sampled. 
The different lower sediment formations are shown by different colouring, and the areas for the sampled 
regions for Well I and Well II are indicated.” (Lewin, 2013) Distance in meters are given in the horizontal 
and vertical axis. 
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1.2 Protein classes of interest for industrial processes 
The Structure-Function Linkage Database (SFLD) classifies predicted enzymes based 
on specific sequence-structure features to specific chemical capabilities, hence 
hypothesizing function. In this database an enzyme family is defined as a group of “[…] 
evolutionary related proteins that catalyse the same overall reaction in the same way.” 
(Hicks, 2014). A protein is clustered into a family of which it has high sequence or 
structural similarity to the other family members, i.e. they are homologous. Some 
families are divided into subfamilies when there is evidence for an ancient divergence 
corresponding to more than 150 point mutations per 100 amino acid residues. This 
number of point mutations represents a time line of 2500 million years, when calculated 
with the typical evolutionary rate (0.6 substitutions per amino acid per 1000 million 
years (Rawlings, 2007). Annotation of enzymes normally includes the assignment of a 
class within the Enzyme Commission (EC) Scheme presented by the NC-IUBMB 
(Moss, 1992). An enzyme is assigned four numbers, where the first represents one of 
the six main classes of reactions catalysed (oxidoreductases, transferases, 
hydrolyses, lysases, isomerases or lipases, respectively). The second and third 
number represents the sub and sub-sub class of the overall reaction and the fourth 
number indicates substrate specificity.  
Since ancient time have enzymes found in nature been used on production of foods 
such as cheese, sourdough, wine and beer. Over the last five decades, there has been 
a massive development in the enzyme industry. Thanks to manufacturing of purified 
enzymes and recombinant gene technology, along with protein engineering, it has 
been made possible to provide enzymes tailor-made for the process of interest. Today, 
enzymes are used in countless industrial processes, from active components in 
detergents and hygiene products to textile and paper production. Of all the enzymes 
used industrially, peptidases remain the dominant type due to its extensive use in 
detergent and dairy industries. While the second largest group is represented by 
various carbohydrases, primarily amylases and cellulases (Kirk, 2002).  
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1.2.1 Peptidases  
Peptidases are ubiquitous enzymes, essential for the survival of all living organisms. 
The digestion of food proteins, antigen presentation of the immune system and 
regulation of blood clots, as well as post-translational maturation of enzymes, peptide 
hormones and neurotransmitters, are some biological processes where peptidases 
play an important role. Peptidases have been used for several industrial processes, 
from clotting cheese and processing of other foods to being one of the active agents 
in detergents. Other commonly used names for peptidases are proteases, proteinases 
and proteolytic enzymes, but peptidases is the term recommended by the 
Nomenclature Committee of the International Union of Biochemistry and Molecular 
Biology (NC-IUBMB) and the Human Gene Nomenclature Committee (Kirk, 2002, 
Rawlings, 2007). 
A peptidase is an enzyme that hydrolyses peptide bonds, and therefore belongs to the 
third EC class. The reaction on peptide bonds is assigned subclass number four, hence 
all peptidases have the EC number 3.4.X.Y., where the X represents the sub-sub class, 
and the Y indicates substrate specificity. There are six main catalytic types of 
peptidases recognized. Serine, threonine, cysteine, aspartic, glutamic and metallo- 
peptidases, indicating what chemical group is responsible for hydrolysing the peptide 
bond. The catalytic nucleophile of the serine, threonine and cysteine type is the 
reactive group of the amino acid side chain, while an activated water molecule is the 
nucleophile of the metallo- and aspartic type. For metallo- peptidases the metal ion, 
which most commonly is zinc but it can also be cobalt, copper or manganese, is 
tetrahedrally coordinated by three amino acid residues and the activated water 
molecule (Rawlings, 2007). The glutamic peptidases have a catalytic dyad of Glu/Gln. 
This peptidase type was not recognised until 2005, and there is still much to learn 
about its mechanism (Rawlings, 2007) (Yabuki, 2004).  
Structural analysis of peptidases have shown that the active site is commonly located 
in a groove on the surface of the enzyme. The catalytic mechanisms of peptidases 
varies between and within classes (depending on which classification method used), 
but can be described as an acid-base reaction, where the nucleophile acts as the 
proton donor and an amino acid residue (called the general base) is the proton 
acceptor. The active site residues are well conserved for peptidases within a family 
(Rawlings, 2007).  
Introduction 
10 
 
Classification of peptidases based on chemical mechanism of catalysis is not optimal. 
For example, even though all serine peptidases contain a serine residue that acts as 
the nucleophile, they have many different molecular structures and catalytic 
mechanism. In other words, they are not all homologous to each other (Rawlings, 
2007). There exists two other ways of classifying peptidases as well. One is by the kind 
of reaction they catalyse, i.e. endo- or exopeptidases, while the last and newest 
method of classification uses molecular structure and homology to group peptidases. 
 
Endopeptidases 
The general characteristic of endopeptidases is that they cleave internal peptide bonds 
in proteins and larger polypeptide chains. Acting distant from the existing N- and C-
termini, endopeptidases generate new termini that can function as substrate for 
exopeptidases, for instance in food digestion. There are endopeptidases that can only 
hydrolyse peptides that are smaller than proteins, called ‘oligopeptidases’.  
The endopeptidase group includes several enzyme classes (as classified by the EC 
Scheme). One of these are the serine peptidases (EC: 3.4.21.Y). For serine peptidases 
the proton donor and acceptor along with a third member makes up the catalytic triad 
of the active site, represented by a serine, histidine and aspartate residue, respectively. 
The serine residue anchors the acyl-enzyme intermediate during the reaction, while 
aspartate orientates the imidazolium ring of the proton donor histidine and helps 
charge one of the nitrogen atoms in the ring. One family of serine peptidases is the 
subtilisins. Most of the subtilisins are endopeptidases, meaning that they hydrolyse a 
peptide bond away from the N- or C-terminus. Most subtilisins are extremely 
thermostable, making them suitable for many industrial applications (Rawlings, 2007).  
 
Exopeptidases  
Exopeptidases hydrolyse peptide bonds within three residues from the terminus of a 
polypeptide, and therefore requires a free amino or carboxyl group, or both.  
There are six types of exopeptidases. Amino- and carboxypeptidases release a single 
amino acid residue from the N’- and C’-terminus, respectively, needing only the one 
end group free. Dipeptidyl-peptidases and peptidyl-dipeptidases both release a 
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dipeptide from its substrate N’- or C’- terminus, respectively. Dipeptidases hydrolyse 
dipeptides and need both end groups free. However, the term ‘dipeptidase’ is often 
used for any peptidases that release dipeptides from their substrate. The last type, 
tripeptidyl-peptidases cleaves off a tripeptide from the N’-terminus (Rawlings, 2007). 
Since their hydrolytic activity is on the N’-terminus, the term ‘aminopeptidase’ is also 
used for the di- and tripeptidyl peptidases. Aminopeptidases are involved in many 
proteolytic pathways such as protein maturation, hormone level regulation and cell-
cycle control, but they seem to act in coordination with other peptidases to fulfil these 
roles. As they are of such importance to cellular processes, they are of interest to the 
pharmaceutical industry (Brown, 2003, Sanz, 2007).  
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1.3 Recombinant expression systems 
The use of recombinant proteins have increased a great deal over the past decade, so 
naturally, the resources spent on understanding and developing better recombinant 
systems have increased as well. Bacterial systems are mostly used due to high 
productivity using inexpensive substrate media, as well as their well-characterized 
genetics, which has resulted in many available cloning vectors and mutant host strains 
(Terpe, 2006). All bacteria can be used for recombinant protein production, but 
Escherichia coli is the most common. This Gram-negative bacterium is cheap to grow, 
it grows rapidly, is well known and has been established in most laboratories since the 
birth of molecular cloning in 1973 (Cohen, 1973). However, a downside with using 
E. coli as a host is that recombinant proteins are often produced in insoluble and 
non-functional form (Sørensen, 2005). 
To obtain a high level of the target protein it is often needed to clone the gene 
downstream of a well understood and regulated promoter in the vector used. Choosing 
the best host and promoter system for a specific protein is not always straight forward, 
and often depends on the heterologous protein itself. Many bacterial systems are not 
able to perform the correct posttranslational modifications that can be essential for the 
activity of the target protein (Terpe, 2006). There is no guarantee that the product of 
the recombinant gene will successfully be produced in its active form, but many 
modified strains of host cells and vectors utilising different promoter systems have 
been developed to overcome some of the different challenges.  
 
1.3.1 T7 RNA polymerase system  
The naturally occurring lac operon of E. coli has for many years been used to 
regulate the bacterium, and most of the promoters developed to induce heterologous 
production have elements derived from this. The T7 RNA polymerase system is one 
of the most widely used promoter systems for E. coli, and its use in the pET vector 
has become very popular (figure 1.3). The target gene is cloned into pET plasmids 
downstream of a strong bacteriophage T7 promoter, so a source of T7 RNA 
polymerase is needed to induce expression (Tabor, 2001). The host cells, 
transformed with the pET plasmids, contain a prophage (e.g. λDE3) encoding the T7 
RNA polymerase under the control of the isopropyl-β-D-1-thiogalactopyranoside 
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(IPTG) inducible lac derived promoter lacUV5 (Baneyx, 1999). This system has 
several advantages, such as several times faster RNA elongation compared to the 
bacterium’s own RNA polymerase, the termination of transcription is less frequent, 
and it allows the target gene to be cloned with low transcriptional activity. This is 
important as even a low expression of the heterologous protein can interfere with the 
metabolism of the host cell, and in that way be toxic to the cell (Tabor, 2001). 
 
 
Figure 1.3: Plasmid map of the pET21(+) vector. This plasmid contains a ampicillin resistance gene 
(green), two origins of replication (yellow), the lacI gene (red), MCS (light blue) and lac operator 
(turquoise) (www.snapgene.com/resources).  
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1.3.2 Host strains  
Many mutant host strains have been developed for E. coli to address some of the 
limitations met when producing heterologous proteins. The most commonly used are 
BL21 and K-12, and their derivatives (Terpe, 2006). BL derivatives are deficient in the 
E. coli endogenous proteases lon and ompT, which have been proven involved in 
degradation of recombinant proteins (Jiang, 2001). Other common mutations are 
regarding tRNAs. The abundances of the various tRNAs differs between organisms. 
Forced over-expression of heterologous proteins can exhaust the pool of tRNAs rare 
to the host bacterium, causing the translation to stall. For this reason, several strains 
of the BL21 have been modified to contain extra copies of tRNA genes. These are 
collectively given the name “CodonPlus” (Terpe, 2006). As an example, the strain 
BL21-CodonPlus(DE3)-RIPL contains extra copies of the argU, ileY, leuW and proL 
tRNA genes, which collectively recognises the codons AGA, AGG, AUA, CCC and 
CUA. 
In λDE3 cells, there is observed some T7 polymerase activity, even in the absence of 
IPTG. This ‘leaky’ expression from the lacUV5 promoter can cause the growth rate of 
the bacteria to decrease, or in worst-case cause cell death due to possible toxic 
effects of the heterologous protein. The amount of plasmid containing the target gene 
may therefore not be very high for these strains. For this reason, target genes are 
initially cloned into a host that does not contain the gene for T7 polymerase, to 
ensure the establishment and propagation of the gene carrying plasmid (Tabor, 
2001). A commonly used host strain for this purpose is the E. coli DH5α. This strain 
carries recA1 and endA1 and other mutations for increased insert stability, and has a 
high transformation efficiency (Taylor, 1993).   
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1.3.2 Vectors 
A vector is a self-replicating DNA molecule which can be used to carry cloned genes 
or other fragments of DNA between hosts. Minimum requirements for a cloning 
vector are that it should be a reasonable small DNA molecule, easy to transfer 
between cells and straightforward generation and purification of large amounts of 
vector DNA. Plasmids are DNA molecules found in both prokaryotic and eukaryotic 
cells. Most are circular molecules of double stranded DNA, carrying genetic 
information but they are not chromosomes or part of the cell’s permanent genome. 
The first vectors to be used were derivatives of small multicopy plasmids of bacteria, 
and they are still the most widespread. In addition to the natural characteristic, vector 
used today have been modified with artificial improvement making it easier to detect 
and select the cells carrying the vector. Genetic information not needed is removed, 
and genes encoding, for instance, antibiotic resistance are added. Antibiotic 
resistance is used for direct selection of clones containing the vector, by incubating 
the cells in media containing the antibiotic of choice. A second feature commonly 
added to plasmids is a ‘multiple cloning site’ (MCS). This is a sequence of DNA 
synthesized to include several sites for frequently used restriction enzymes (see 
section 1.3.4. below for more details on restriction enzymes). The rest of the vector 
should not contain any of the restriction sites used in the MCS, which ensures that 
the insert is cloned in the same location every time (Clark, 2010).  
Many derivatives of plasmids and other vectors have been developed for use in 
recombinant gene technology, and finding the best fit can be difficult and is often 
done by ‘trial-and-error’. For this thesis, two plasmids were initially chosen for the 
cloning of candidate genes. Plasmid pET21, mentioned above, is a much used 
plasmid for recombinant gene expression, as it utilizes the T7 RNA polymerase 
system for strong and regulated expression of the target gene. Other than the T7 
promoter, this plasmid also contains the gene for ampicillin resistance (amp), a MCS 
with restriction site for AvaI, XhoI, NotI, EagI, HindIII, SalI, EcoRI and BamH, a 
bacterial origin of replication (ori) and a phage ori (f1) (Dana-Farber/Harvard Cancer 
Center, 2004-2014). The second plasmid is the pUC57 plasmid, a derivative of 
pUC19. Its MCS contains six restriction sites with protruding 3’-ends, which are 
resistant to E. coli exonuclease III, and it also carries the gene bla for ampicillin 
resistance (GenScript).  
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1.3.4 Restriction endonucleases 
Restriction endonucleases (RE) are enzymes that can be found in prokaryotes. Here 
they protect the organism from viruses and other infectious DNA molecules by 
recognising specific sequences in double-stranded DNA (restriction site) and cut the 
DNA at that site. They are classified into four different types (I-IV), where type II is the 
largest class with over 350 different prototypes known and over 200 of them being 
commercially available. It is this type of restriction enzymes that gave rise to 
recombinant DNA technology after their discovery in the 1970’s (Loenen, 2014, 
Pingoud, 2014).  
The choice of which cloning strategy to use can affect the choice of vector, as the 
needs for certain restriction sites to be present and the reading frame of the target 
gene to be compatible. The restriction enzymes used for cloning should not have sites 
within the target gene or more than needed to prepare the vector fragment, as this 
drastically decreasing the odds of re-ligating a functional vector.  
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1.4 Purification methods 
In order to analyse and characterize recombinant proteins, separating them from other 
proteins produced in the host cell is often necessary. The utilization of the bio-valuable 
compounds identified through metagenomic analysis would not have been as 
successful if individual purification techniques had to be developed for each protein 
type. Affinity tags, such as the commonly used histidine tag (His-tag), allow for 
purification of most proteins without knowing anything about its biochemical properties 
(Arnau, 2006). The His-tag is added by modifying the recombinant DNA sequence to 
contain nucleotides encoding 5-15 histidine residues on the  N’- or C’-terminus of the 
target gene. The His-tag can be positioned at either end of the gene sequence, but it 
is argued that the risk of it affecting the post-translational modifications is lower when 
applied at the stop-codon-end (Sancho, 1992). The purification is possible due to 
histidine’s affinity for the metal ions Ni2+, Co2+, Cu2+ and Zn2+, and is performed using 
immobilized metal-ion affinity chromatography (IMAC).  
When the protein of interest is thermostable, as assumed for this study, it is possible 
to purify the protein sample by heat denaturation. By subjecting the sample to heat, 
e.g. 65°C, proteins not stable at this temperature will denature and become insoluble 
while thermostable proteins will remain soluble. Most of the proteins produced by 
mesophiles, such as E. coli, will denature at temperatures above 40 °C (Torrez, 2003). 
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2. AIM OF PROJECT 
 
The aim of this master project was to identify thermostable peptidases encoded in an 
oil reservoir metagenomic sequence database, and produce these using recombinant 
gene technology.  
This metagenomic DNA sequence library has previously been exploited to identify 
thermostable enzymes from other classes. As peptidases are ubiquitous enzymes, 
essential for all living organism, there was of interest to include gene candidates from 
this class. If successful production of the enzyme candidates is obtained, functional 
characterization is needed to further develop the proteins for application in industrial 
processes (figure 2.1). 
Figure 2.1: Schematic overview of steps performed in I previous project to make the metagenomic DNA 
sequence library used in this project to identify putative gene sequences for thermostable peptidases. 
These candidates were expressed using recombinant gene technology and bioactivity assays was 
performed for functional characterization. 
Materials 
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3. MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Chemicals  
Chemicals used in this study are listed in table 3.1, together with the purity of the 
substance, its supplier and country of production. 
Table 3.1: Chemicals. 
Chemical Purity Supplier Country 
Acetic acid 99.9 % VWR International France 
Agar Bacteriological N/A OXOID Ltd. UK 
Ampicillin sodium salt  ≥91.0 % AppliChem Germany 
Calcium chloride 99.8 % VWR International  Belgium 
D-(+)-Glucose anhydrous ≥99.5 % VWR International  Belgium 
EDTA (ethylene-diamine- 
tetraacetic acid) 
≥99.5 % Sigma-Aldrich Germany 
Ethanol 100.0 % VWR International  France 
Glycerol ≥99.5 % VWR International  France 
IPTG (Isopropyl  
β-D-1-thiogalactopyranoside) 
≥98 % VWR International  Belgium 
iso-Propylalchohol 100 % VWR International France 
Magnesium sulphate heptahydrate ≥99.5 % VWR International Belgium 
Manganees II Cholide ≥98 % Avantor Performance Materials B.V. Mexico 
MOPS (3-morpholinopropane- 
1-sulfonic acid) 
≥99.5 % Research Organics USA 
Potassium acetate ≥90.0 % Merck KGaA Germany 
Potassium chloride ≥99.5 % Merck KGaA Germany 
Rubidium chloride ≥99 % AMRESCO USA 
Skim milk powder N/A OXOID Ltd. UK 
Sodium chloride 99.9 % VWR International Belgium 
Sodium hydroxide ≥99 % VWR International UK 
Trichloroacetic acid ≥99.5 % Sigma-Aldrich Germany 
Tris-(hydroxymethyl) aminomethane 99 % VWR International Belgium 
Tryptone N/A OXOID Ltd. UK 
Yeast extract N/A OXOID Ltd. UK 
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3.1.2 Escherichia coli strains and plasmids  
Bacterial strains and plasmids used for this study are listed in table 3.2, below. 
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3.1.3 Media and solutions  
Water purified by Milli-Q purifiers, was used to prepare solutions and media if not 
otherwise specified. The components of all media prepared and used for this project 
are listed in table 3.3. 
Table 3.3: Compounds and their amounts needed to prepare the media Luria Broth (LB), LB agar (LA), 
skim milk agar (MA), Psi* and Super Optimal Broth (SOC). 
 LB (g/L) LA (g/L) MA (g/L) Psi* (g/L) SOC (g/L) 
Yeast extract 5 5  5 5 
Tryptone 10 10  20 20 
NaCl 10 10   0.5 
Agar  15 15   
Skim milk 
powder 
  16   
MgSO4    10.26 4.8 
Glucose     3.603 
*Psi represents a simple medium similar to LB, with added MgSO4, to increase cell density (Studier, 
2005). 
The compounds listed in table 3.3 were weighed in and mixed before the medium was 
autoclaved. For the SOC medium, the pH was adjusted to 7.6 using KOH, before 
autoclaving. Media not containing agar were stored at room temperature. When 
needed, premade solution of ampicillin was added to the medium to a final 
concentration of 100 µg/ml. To minimize degradation and ensure maximum effect of 
the antibiotic, Ampicillin was added after the medium had cooled to <50 °C (following 
autoclaving) and just before inoculation with bacteria.  
Media containing agar (LA and MA) were cooled to 50 °C, and ampicillin added, before 
casting the petri dishes (20-25 ml/dish). The plates were left to solidify before being 
stored upside down in the dark at 4 °C. For some of the MA plates, 40 µl 0.1 M IPTG 
was added, after the plates had solidified. 
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The solutions TFB I and II were used to make competent cells for transformation. Table 
3.4 lists the components, and their amount, mixed to prepare these solutions. 
Table 3.4: Components and their amount used to prepare 200 and 100 ml of TFB I and II, respectively.  
 TFB I TFB II 
Potassium acetate 0.588 g - 
Rubidium chloride  2.42 g 0.121 g 
Calcium chloride  0.294 g 1.1 g 
Manganese (II) chloride  15 g - 
MOPS - 0.21 g 
Glycerol (15 v/v) 30 ml 15 ml 
 
The solids were weighed out and mixed with most of the water. The pH was adjusted 
to 5.8 using diluted acetic acid for TFB I, and pH 6.5 using NaOH for TFB II, before 
additional water was added to make a total of 200 and 100 ml, respectively. The 
solutions were then filter sterilized and stored at 4 °C.  
 
Buffers TE, TAE and Tris-HCl was used for this study. Table 3.5 lists the components, 
and their amount, mixed to prepare these solutions. 
Table 3.5: Components and their amount to prepare the buffers Tris-HCl, TE and TAE. pH was adjusted 
to 8 using the solutions listed. 
 Tris-HCl (g/L) TE (g/L) TAE (g/L) 
Tris-(hydroxymethyl) 
aminomethane 
121.14 12.11 4.85 
EDTA - 7.44 0.37 
Acetic acid - - 1.20 
pH adjusted to  8 8 8 
pH adjusted with HCl NaOH NaOH 
 
After mixing the solutions, the Tris-HCl and TE buffer was filter sterilized and stored at 
room temperature. 
Methods 
23 
 
3.2 Methods 
3.2.1 Bioprospecting for peptidases in the oil reservoir metagenome database 
Searches for enzymes that are not membrane bound, belong to the enzyme 
classification number 3.4, and are smaller than 1000 amino acid, was performed in the 
protein sequence database UniProt. Peptidase sequence candidates were identified, 
using only annotated FASTA nucleotide sequences of known proteases. Sequence 
similarity searches were performed using BLAST, to identify local alignments of the 
chosen peptidases to nucleotide sequences in the given metagenomic database from 
oil reservoirs 1 and 2. ORF Finder was used to predict open reading frames of the 
contigs showing high percentage of identity to the chosen peptidase sequences, and 
candidates displaying possible truncated (non-complete) protein sequences were 
eliminated from the candidate list. The FASTA protein sequence was used for BLAST-
based homology searches against proteins in the NCBI Protein Data Bank. Highest 
percentage identity structures were used to check the presence of conserved active 
site residues in the candidate gene sequence. The presence of start and stop codon 
and Shine-Dalgarno sequence was also checked before listing the protein as a finale 
candidate. The final elimination was based on the enzyme class and function, 
homology to species of interest, as well as the length of the gene (budget limitations). 
The synthesis of the putative gene candidates, and cloning into pUC57 vectors, were 
ordered from GenScript (www.genescript.com). Each gene was constructed with 
addition of nucleotides providing restriction sites for NdeI, XhoI, BglII and BclI, a His-
tag and protective bases flanking the gene, before it was cloned into pUC57 plasmids 
using EcoRV. The complete DNA sequence, including restriction sites, His-tag and 
protective bases, for each of the gene candidates can be seen in appendix A.1. 
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3.2.2 Preparing chemically competent cells 
Three strains of Escherichia coli, DH5α, BL21 (DE3) codon plus RIPL, and ER2566 
(table 3.2), were used for preparing chemically competent cells for transformation. 
Cells of the frozen bacteria strain were used to inoculate 5 ml of psi medium (table 3.3) 
and incubated at 37 °C at 225rpm overnight. 1 ml of the overnight (O/N = 12-16 hours) 
culture was inoculated in 100 ml of psi medium, and incubation was continued at 37 °C 
at 225 rpm until optical density (OD) at 600 nm reached ~0.4. The cells were incubated 
on ice for 15 minutes before centrifuged (4500 rpm, 5 min, 4 °C) using a Biofuge 
primoR centrifuge from Heraeus (rotor #7590). While on ice, the cell pellet was re-
suspended in 40 ml cold TFB I, centrifuged (4500 rpm, 5 min, 4 °C) and re-suspended 
in 3 ml cold TFB II. The cells where transferred to sterile 1.5 ml Eppendorf tubes, 100 
µl/tube, and snap frozen using liquid nitrogen. All competent cells were stored 
at -80 °C. 
  
3.2.3 Sub-cloning of candidate genes in pET21 
All the pUC57_gene plasmids were shipped from GenScript in tubes containing of 4 µg 
dried DNA. TE buffer (40 µl) was added to dissolve and dilute the plasmids to a final 
concentration of 100 ng/µl. Plasmid preparations, already isolated, of pUC57_APT01, 
pUC57_CPT01 and pOD1 were used for this cloning step. These preparations were 
obtained using the Wizard Plus SV Minipreps DNA Purification System from Promega, 
from E. coli DH5α cells transformed in the initial attempt to include the His-tag. DNA 
concentrations of these isolations were measured using the NanoDrop 1000 
Spectrophotometer (Thermo Scientific). The third candidate, pUC57_SLP01, was used 
directly from the tube provided by GenScript.  
Enzyme digestion of the pUC57_gene and the pOD1 plasmids was performed using 
restriction enzymes NdeI and XhoI as shown in table 3.6. The amounts of plasmids 
used were adjusted from concentration of DNA in the plasmid preparations, to give a 
vector-to-gene ratio of 1:9. The reaction mixtures were mixed, and incubated in a 37 °C 
water bath for 90 minutes. 
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Table 3.6: Reaction mixtures used to digest pUC57_APT01, pUC57_CPT01, pUC57_SLP01 and 
pOD01 using the restriction enzymes NdeI and XhoI. 
 pUC57_ 
APT01 (µl) 
pUC57_ 
CPT01 (µl) 
pOD1 (µl) 
(for APT01  
and CPT01) 
pUC57_ 
SLP01 (µl) 
pOD1 (µl) 
(for SLP01) 
Plasmid prep. 30 37 50 5 8 
NEB Buffer 3.1 6 6 6 1,5 1,5 
dH2O 22 15 2 6,5 3,5 
NdeI 1 1 1 1 1 
XhoI 1 1 1 1 1 
Total  60 60 60 15 15 
Loading dye 7.5 7.5 7.5 1.85 1.85 
 
The fragments from the enzyme digest were separated using agarose gel 
electrophoresis. The gel was prepared using agarose solution containing 0.8 % 
agarose and 20 µl Gel Green (per 400 ml). Sample loading dye (10mM Tris-HCl pH7.6, 
0.03 % bromophenol blue, 0.03 % xylene cyanol FF, 60 % glycerol and 60 mM EDTA) 
was added to the reaction mixtures as seen in table 3.6, before the samples were 
added to separate gel wells. Electrophoresis was run at 75 volts for approximately 60 
minutes. 
A molecular imager (Gel DocTM XR+ system from BioRad) was used to visualize the 
DNA bands by UV light. Fragments were excised from the gel and purified using the 
QIAquick Gel Extraction Kit Protocol (QIAGEN). The standard protocol (for 
microcentrifuge) provided by the manufacturer was followed with two modifications. 
The washing step 10 was repeated using 500 µl of Buffer PE, and that the DNA was 
eluted in step 13 using 30 µl sterile deionized nuclease free water to increase its 
concentration. The eluted DNA was used directly for ligation of candidate genes into 
pET21 expression vector to form pET21_gene. The ligation mixture contained 30 µl of 
the gene fragment, 10 µl of the vector fragment, 1 µl T4 DNA ligase and 4 µl T4 DNA 
ligase buffer. For the negative control reaction, dH2O was added in place of the gene 
fragment. The ligation mixtures were incubated O/N over ice. After incubation, the 
ligation mixtures were stored at -20 °C until transformation later the same day. 
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3.2.4 Transformation of E. coli DH5α with pET21_gene 
Chemically prepared competent E. coli DH5α cells were transformed with recombinant 
pET21_gene plasmids, using heat shock transformation. Tubes containing frozen 
competent cells (section 3.2.2) were thawed on ice before 50 µl each were transferred 
to new pre-chilled 1.5 ml Eppendorf tubes for each transformation reaction. While on 
ice, the ligation mix for pET21_APT01 (10 µl), pET21_CPT01 (10 µl), 
pET21_SLP01 (5 µl) and re-ligated pOD1 (10 µl), were added to the cells and 
incubated for 30 minutes on ice. For the negative control, competent cells with no 
addition of plasmid DNA was used, while pUC57 plasmids carrying a transposon 
fragment (pUC57_FragT1) obtained from GenScript for a previous project, was used 
as a positive control. The cells were exposed to a heat shock in a water bath at 42 °C 
for 45 seconds, then incubated for two minutes on ice. SOC medium (250 µl), pre-
warmed to 37 °C, was added, and the cells were incubated at 37 °C at 225 rpm for one 
hour, before being plated on LA plates for growth and selection of successful 
transformants. The plates were incubated at 37 °C O/N, and then stored in at 4 °C until 
further use. 
 
3.2.5 Verification of correct insert 
Verification of correct pET21_gene construct was confirmed by restriction digestion 
and separation by gel electrophoresis. Using sterile toothpicks, twelve single colonies 
for each of the three pET21_gene plasmids, and the pOD1 control, were streaked out 
on a new plate and inoculated into 13 ml tubes containing 5 ml of LB medium and 
ampicillin. Both plates and tubes where incubated at 37 °C O/N, the tubes in a shaking 
incubator at 225 rpm. The plates were moved to 4 °C the next day, and stored at this 
temperature. Plasmid preparations were made for each of the O/N cultures using the 
Promega Wizard® Plus SV Minipreps DNA Purification System Protocol. The 
centrifugation, in step 3.B.1, was preformed directly on the 13 ml tubes used for 
incubation of the O/N cultures. The supernatant was discarded and 250 µl Cell 
Re-suspension Solution was used to completely re-suspend the cells, before 
transferring the entire sample to a sterile Eppendorf tube. The DNA was eluted using 
100 µl nuclease free water. 
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Restriction digestion was performed on the plasmids, using BglII restriction enzyme for 
pET21_APT01 and pET21_CPT01, and NdeI and XhoI for pET21_SLP01, due to 
differences in restriction sites. All samples were incubated in a water bath at 37 °C for 
2 hours, before the samples were separated using gel electrophoresis as described 
above.  
A larger volume of plasmids preparation stock was prepared for recombinant protein 
production. Based on the results from the verification step, single colonies originating 
from one of the newly streaked CFUs carrying the correct insert were used to prepare 
4x 5 ml O/N cultures, for each pET21_gene candidate. Plasmid preparation was 
performed as described above. The concentrations of the plasmid preparations were 
measured using NanoDropTM 1000 Spectrophotometer (Thermo Scientific). 
 
3.2.6 Recombinant protein production 
The BL21 (DE3) codon plus RIPL strain of E.coli was chosen for production of the 
recombinant proteins. Cells of this strain were made competent for transformation by 
the procedure explained in 3.2.2. The final plasmid preparations from 3.2.5 were used 
to transform these cells by heat shock transformation as in 3.2.4, but changing the heat 
shock duration to 20 seconds. Single colonies of transformed BL21 cells, were used to 
prepare O/N pre-cultures (5 ml LB +amp, at 37 °C, 225 rpm). From these, 1 ml was 
used to inoculate 100 ml LB with ampicillin in 500 ml Erlenmeyer flasks with baffles. 
The cultures were incubated in a shaking incubator at 37 °C and 225 rpm. The optical 
density was measured spectrophotometrically at a wavelength of 600 nm. When the 
OD600nm value was close to one, the 100 ml culture in the flasks was divided into 2x 
50 ml and transferred to two 250 ml flasks. IPTG was added, to a concentration of 0.5 
mM, to one of the two parallels, while the respective other 50 ml culture was handled 
equally further without induction and served as a negative control. The eight flasks 
where subsequently incubated (37 °C, 225 rpm) and the absorbance was measured 
every hour until the bacteria cultures reached a stationary growth phase. The cultures 
were then transferred to 50 ml tubes and centrifuged at 6500 rpm for 10 min at 23 °C, 
using a Biofuge primoR centrifuge from Heraeus (rotor #7590). The supernatant was 
discarded and the pellet was stored at -20 °C until cell lysis was performed the following 
day. 
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3.2.7 Isolation of proteins 
To isolate the proteins produced intracellularly, the cells were lysed by sonication. The 
pellet samples obtained in 3.2.6 were thawed and cells of each re-suspended in 10 ml 
0.1 M Tris-HCl buffer (pH 8) and sonicated for 7x 1 minute with intermittent mixing. 
Sonication was performed using a Branson Sonifier equipped with a double stepped 
microtip (3 mm), set to duty cycle at 40% and output control set to 4. Centrifugation for 
30 minutes at 20 000 g and 4 °C followed. Due to uncertainties regarding the solubility 
of the produced target proteins, both the supernatant and pellet samples were saved 
for further analysis. The supernatant was distributed into 1.5 ml Eppendorf tubes, some 
stored at 4 °C and some at -80 °C. The pellet, representing the insoluble fraction, was 
stored at -80 °C. 
  
3.2.8 Detection of protein using SDS-PAGE 
SDS-PAGE (sodium dodecyl sulphate polyacrylamide gel electrophoresis) was used 
to detect production of target proteins. Premade gels (12 % acrylamide, 12 wells) and 
running buffer (FB60500), provided from C.B.S. Scientific, was used for all SDS-PAGE 
experiments preformed in this study. The protein size reference marker used was the 
Precision Plus Protein Unstained Standards from Bio-Rad, and the BioSafeTM 
Coomassie G-250 Staining Solution from the same supplier was used to stain the 
proteins separated in the gel.  
Samples from both pellet and supernatant of induced and non-induced cultures of all 
three candidates and the pOD1 control were prepared for electrophoresis. For each of 
the eight supernatant samples, one tube stored at -80 °C was thawed and 24 µl was 
transferred to a new sterile Eppendorf tube. SDS-PAGE 5x DTT loading buffer (0.25 % 
Bromophenol blue, 0.5 M DTT, 10 % SDS and 50 % glycerol) was added (6 µl). For 
the pellet samples, a small amount of frozen pellet was suspended in an Eppendorf 
tube containing 80 µl of 0.1 M Tris-HCl (pH 8), and 20 µl of loading buffer was added 
to each. All 16 samples were incubated on a heat block at 95 °C for 10 minutes, then 
centrifuged using a 5415R microcentrifuge from Eppendorf, for 5 minutes at 5000 rpm 
at 23 °C. For each sample, 5-25 µl was loaded to a well and the SDS-PAGE was run 
at 175 volts for 35-45 minutes. 
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To increase the concentration of protein in the supernatant samples, TCA precipitation 
was performed prior to the preparation of the samples with DTT loading dye. A protocol 
from the Björkman Group at the California Institute of Technology (BjörkmanGroup, 
2001) was followed, using 800 µl of protein sample and 200 µl of TCA stock (5 g 
Trichloroacetic acid dissolved in 3.5 ml H2O). When the precipitation procedure was 
complete, 50 µl of 0.1 M Tris-HCl (pH 8) and 15 µl of DTT loading buffer was added 
and the samples where heated, centrifuged and run on a gel as explained above. 
 
3.2.9 Recombinant protein production using other parameters   
An alternative production host strain was tested for the SLP01 candidate. The plasmid 
pET21_SLP01 and the control plasmid pOD1 were used to transform competent cells 
of E. coli ER2566, as described in 3.2.4, with a heat shock at 42 °C for 20 seconds. 
The second attempt of recombinant protein production was carried out in BL21 cells 
for all three constructs and ER2566 SLP01 candidate. The method was equal to that 
presented in 3.2.6, with the exception that the temperature during incubation after 
induction with IPTG was set to 16 °C. Incubation was ended and cells were centrifuged 
(as above) when OD600nm-values stabilized. Lysing of cells using sonication and 
detecting of proteins by SDS-PAGE was done as described in 3.2.7 and 3.2.8. 
A third attempt was performed using 1 litre cultures. Transformed E. coli BL21 cells 
with pET21_APT01, pET21_CPT01 and pOD1 was inoculated into 5 ml of LB broth 
containing 100 µg/ml ampicillin at 37 °C for 16 hours. The following day, all of the O/N 
culture (5 ml) was added to a 3000 ml Erlenmayer flask, with baffles, containing 1 litre 
of 3x LB and ampicillin (three times the amount of tryptone and yeast extract, but 
identical amounts of NaCl per litre). The cultures grown in a shaking incubator at 37 °C 
at 180 rpm until OD600 was close to three. IPTG was added to each flask to a total 
concentration of 0.5 mM, and the cultures were subsequently incubated at 16 °C and 
180 rpm for five hours. Absorbance was measured once every hour. Centrifugation 
was done at 12 000 g, for 30 minutes at 14-16 °C. The supernatant was discarded, 
and the pellet were re-suspended using 40 ml, 1 M Tris-HCl (pH 8) and stored at -20 °C, 
until sonication the following day. Isolation and detection of proteins was performed as 
described in 3.2.7 and 3.2.8, with the duration of centrifugation after heat block 
treatment increased to 20 minutes. 
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3.2.10 Heat denaturation series 
A frozen tube of the induced supernatant sample of the BL21 pET21_APT01 culture, 
from the protein production using 50 ml cultures and incubation at 16 °C (section 3.2.9), 
was thawed and 200 µl was transferred to sterile Eppendorf tubes. Using heat blocks, 
samples were subjected to either 65 or 80 °C for different durations of time, as shown 
in table 3.7, and subsequently placed on ice until further processing. 
Table 3.7: Heat denaturation at 65 or 80 °C for 5, 15, 30, 60 or 120 minutes. Sample 11 was a control 
sample, and was not subjected to heat prior to SDS DTT treatment. 
Time 
(min) 
Temperature 
65 °C 80 °C 
5 1 6 
15 2 7 
30 3 8 
60 4 9 
120 5 10 
 
After heat treatment, the 11 samples were centrifuged using a 5415R microcentrifuge 
from Eppendorf for 5 minutes at 13 000 rpm and 23 °C. Each sample was then 
prepared and analysed using SDS-PAGE as explained in 3.2.8. 
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3.2.10 Activity assay using skim milk agar 
To investigate if the E. coli BL21 cells transformed with the pET21_gene (section 3.2.6) 
secreted active proteases, single colonies were streaked out on MA plates with added 
IPTG. BL21 cells transformed with pOD1, and purified proteinase K from Tritirachium 
album (Sigma-Aldrich) was applied as a negative and positive control, respectively. 
Three parallels where made, each incubated at three different temperatures (37, 45 
and 60 °C) for up to 48 hours. 
This activity assay was also used for the supernatant samples obtained from the 
protein production and isolation (sections 3.2.6-3.2.9). Drops of supernatant samples 
were added to MA plates for both induced and non-induced samples for all candidates, 
to test for presence of active peptidases. The negative and positive controls were equal 
to those mentioned above. The plates were incubated at 37 °C for 48 hours.  
Results and discussion 
32 
 
4. RESULTS AND DISCUSSION 
4.1 Data mining 
The aim of this study was to identify and produce new and thermostable peptidases. 
Many steps are included in the process of identifying novel enzymes and producing 
these in host cells. Figure 4.1 shows a flow diagram of the major steps involved in the 
method used for this thesis to search for and select gene candidates of putative 
peptidases. By aligning gene sequences encoding known peptidases to the contigs in 
the given metagenomic DNA sequence library, many different candidates were 
identified. Selecting contigs that were not truncated or genes that was not likely to 
encode membrane bound enzymes increased the possibility of finding candidates that 
could successfully be produced in E. coli in a functional form. Also for this reason, 
sequences that had high sequence identity and coverage to known peptidase genes, 
encoded conserved active site residues, as well as presence of start- and stop codons 
and Shine-Dalgarno sequence were selected.  
Figure 4.1: The five major steps used for the bioprospecting of novel peptidases in the metagenomic 
database. 1: Selected criteria were used to search for annotated peptidases in UniProt. 2: BLAST was 
used to match the nucleotide FASTA sequence of these peptidases to contigs in the metagenomic DNA 
library. 3: The nucleotide sequence of the matching contigs was subjected to NCBI’s ORF Finder to 
locate probable open reading frame of gene of interest. 4: Identified ORFs were validated by the use of 
BLAST against the NCBI database. 5: Selected candidates were synthesized by GenScript to include 
the restriction sites and His-tag shown. “XXX” represents the candidate gene sequence. 
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Through bioprospecting of the metagenomic DNA sequence library, administrated by 
the Core facility bioinformatics at NTNU (BioCore), three protease candidates were 
chosen for cloning, production and characterization. These three putative peptidase 
genes each have a high sequence similarity to a known peptidase of the enzyme sub-
classes: subtilisin-like protease, carboxypeptidase or aminopeptidase. The three gene 
candidates are listed in table 4.1. 
Table 4.1: Predicted function and enzyme class, given name for this study and sequence length in bp 
of the three gene candidates chosen. 
Enzyme class Given 
name 
Function Sequence 
length (bp) 
Subtilisin-like 
protease 
SLP01 Cleaves peptide bonds using serine as 
a nucleophile 
2028 
Carboxypeptidase CPT01 Cleaves peptide bonds at C-terminus 1542 
Aminopeptidase APT01 Cleaves peptide bonds at N-terminus 1530 
 
A minimum requirement when selecting the gene candidates was that they included 
the necessary elements described earlier (start/stop codon, Shine-Dalgarno sequence, 
active site), and had a high – but not too high – sequence identity to a known peptidase. 
The greater the homology, the better chance of identifying genes encoding functional 
peptidases. However, as the aim of this project is to identify novel enzymes, some 
differences in sequence should be present. It was also the intention to choose 
candidates from different sub-classes of peptidases, to have the possibility to 
characterize the different activities.  
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4.1.1 Candidate SLP01 
The peptide sequence of the putative peptidase SLP01 is characterized by 100 % 
coverage and 85 % identity with an annotated subtilisin-like serine protease (662 aa, 
~71 kDa) of Thermococcus kodakaraensis KOD1. T. kodakaraensis is a 
hyperthermophile archaeon that has an optimum temperature of 85 °C, indicating that 
its enzymes are adapted to high temperatures. The SLP01 peptide sequence showed 
88 % identity with 92 % coverage to the crystallographic structure of chain A of the 
protein Pron-Tk-Sp from the same archaea species. Both start and stop codon as well 
as a Shine-Dalgarno sequence could be clearly identified within the contig, and the 
serine, histidine and aspartate residues of the active site are conserved (H180, S359, 
D147, respectively) (Foophow, 2010). Having a great percentage of coverage, and 
quite high result for identity to a hyperthermophile for both nucleotide and protein 
sequence, makes this gene a promising candidate, taking into account that the aim of 
this project was to identify thermostable peptidases. This candidate is the only 
endopeptidase of the three candidates chosen. 
 
4.1.2 Candidate CPT01 
The CPT01 gene is part of a contig in the metagenomic database annotated to the 
bacterium Kosmotoga olearia, strain TBF 19.5.1, and has 100% coverage and 100% 
id with Carboxypeptidase Taq (500 aa, ~58 kDa) from this bacterium. K. oleria was 
isolated from oil production fluid from a platform in the North Sea. It is a thermophile 
with optimum temperature of 65 °C (DiPippo, 2009). It is not surprising that the CPT01 
gene had this high degree of homology to the K. oleria, as it has previously been 
observed that the DNA sequences annotated to K. oleria earlier in this project, have 
high similarities to the published species reference genome of TBF 19.5.1 (Kotlar, 
2011). The CPT01 gene sequence is of interest, despite it having 100 % identity and 
coverage with the enzyme from K. oleria, since this organism is newly sequenced and 
has not been studied to great extent, and is known to be associated with oil reservoirs.   
The gene’s putative protein structure has 98 % coverage and 45 % identity with Chain 
A of the Thermus thermophilus M32 carboxypeptidase, which is a metallo-peptidase. 
The start and stop codons are located within the contig, but parts of the Shine-Dalgarno 
sequence seem to be missing as the start of the contig is only 10 base pairs upstream 
of the start codon. All residues in the T. thermophilus M32 carboxypeptidase 
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associated with the active and its metal binding site are conserved in the CPT01 
sequence (Lee, 2009).   
 
4.1.3 Candidate APT01 
The gene candidate APT01 has high percentage coverage and identity, 97 % and 
77 %, respectively, to the annotated gene for cytosolic aminopeptidase (497 aa, ~53 
kDa) of the DSM 2380 strain of Pelobacter carbinolicus. This bacterium is a mesophile, 
thriving at temperatures between 25-40 °C. Both the start and stop codon as well as 
the Shine-Dalgarno sequence are well defined within the contig. The suggested protein 
structure has 97 % coverage and 46 % identity with the structurally solved chain A of 
the Leucine Aminopeptidase from Pseudomonas putida. The active site residues of 
the homologue Leucine aminopeptidase are conserved within the sequence of 
candidate APT01 (Kale, 2010). This candidate has less homology to annotated 
nucleotide and peptide sequences, compared to the other two. Which makes it an 
interesting choice due to less certainty when it comes to activity and function. 
Aminopeptidases are involved in many cellular processes and are therefore promising 
candidates for the pharmaceutical industry.  
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4.2 Cloning of candidate genes into pET21 plasmid 
A set of vector and host strains was selected for cloning and recombinant gene 
expression. The plan was to clone the gene candidates into the pET21 vector using 
two different routes: One where the genes were directly excised from pUC57 and 
ligated into pET21, and the second where a modification step to include a His-tag was 
first to be carried out before the cloning into pET21. These two routes and further steps 
planned for production and isolation of the enzymes are shown in figure 4.2. 
The chosen gene candidates were synthesized and cloned into pUC57 plasmids by 
GenScript (www.genscript.com). Nucleotides making up the active site for the 
restriction enzyme NdeI were added to the candidate genes where the last three bases 
made up the start codon initiating transcription, and the same was done for the 
restriction enzyme XhoI following the stop codon. This allowed the genes to easily be 
cloned into a different plasmid at a later stage. A modification possibility for a His-tag 
Figure 4.2: Steps for the cloning and expression of the recombinant proteins. Depending on if the gene 
of interest, marked in dark blue, was cut with restriction enzymes BglII and BclI and re-ligated before 
being excised from pUC57, with NdeI and XhoI, and ligated into pET21, the resulting peptide would or 
would not contain a His-tag, respectively.  
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was added at the end of the gene. This included the restriction site for the enzymes 
BglII and BclI followed by a sequence coding for six histidine residues. The three first 
bases of the BclI restriction site also represents a stop codon, terminating the 
transcription before the His-tag if not removed from the sequence. Before each 
candidate was cloned into the plasmid pUC57 by using EcoRV, bases were added to 
either end of the candidate gene for protection. GenScript performed codon 
optimization of the ordered genes for optimized expression in E. coli. Distribution of the 
codon usage frequencies along the sequence was adjusted to 0.89, 0.87 and 0.90 for 
APT01, CPT01 and SLP01, respectively. Here values over 0.8 are considered good, 
and 1.0 is perfect. The GC content was also adjusted to give average values between 
30-70 percent.  
Due to difficulties with ineffective digestion by the restriction enzyme BclI, likely due to 
methylation of the restriction sites, this modification step was put on hold. The second 
(His-tag free) route of the study was prioritized. The plasmid pOD1, containing a gene 
for selenoprotein SelW, was utilised in this project. When digested with restriction 
enzymes NdeI and XhoI the selW gene was removed, leading to the vector backbone 
of pET21. For this report, the vector will be referred to as pOD1 as long as it is carrying 
the selW gene, and pET21 when the gene is removed. Although the initial attempt on 
obtaining the His-tag modifications did not succeed, the plasmid preparations of 
pUC57_APT01, pUC57_CPT01 and pOD1 that were made, were used for cloning the 
APT01 and CPT01 gene into pET21. The concentration of these plasmid preparations 
can be seen in table 4.2. The concentration of pUC57_SLP01 was 100 ng/µl. 
 
Table 4.2: Concentration of plasmid DNA for the preparations made of the pUC57_APT01, 
pUC57_CPT01 and pOD1 plasmid produced in E. coli DH5α.  
Plasmid Concentration (ng/µl) 
pUC57_APT01 111,7 
pUC57_CPT01 87,1 
pOD1 21,7 
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4.2.1 Vector construction 
After both the pUC57 plasmids, containing the genes of interest, and the pOD1 
plasmids had been digested by the restriction enzymes NdeI and XhoI, the DNA 
fragments were separated using gel electrophoresis. Images of the obtained gels are 
shown in figure 4.3 and 4.4. 
 
Figure 4.4: Gel electrophoresis run with fragments of plasmids cut with restriction enzyme NdeI and 
XhoI. The 1kb DNA ladder from GeneRuler TM was a run in the lanes marked “L”, the size of the given 
fragments is given in number of base pairs in red. The plasmid pUC57 containing SLP01 was run in the 
lane marked “SLP”, while the plasmid pOD1 was run in the lane marked “pOD1”. The gene fragment of 
interest is marked with a green box, while the vector fragment of interest is marked with a blue box. 
 
Figure 4.3: Gel electrophoresis run with fragments of plasmids cut with restriction enzyme NdeI and 
XhoI. The 1kb DNA ladder from GeneRuler TM was a run in the lanes marked “L”, the size of the given 
fragments is given in number of base pairs in red. The plasmid pUC57 containing APT01 and CPT01 
was run in the lanes marked “APT” and “CPT”, respectively, while the plasmid pOD1 was run in the 
lanes marked “pOD1”. The gene fragments of interest is marked with green boxes, while the vector 
fragments of interest is marked with blue boxes. 
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The expected fragment sizes after this restriction enzyme digestion and gel separation 
for the pUC57 plasmids were; 1523 bp for APT01, 1535 bp for CPT01, 2021 bp for 
SLP01 and 2727 bp for the remaining vector (pUC57). For pOD1, the fragment of 
interest, the vector itself, was expected to have a size of 5365 bp, while the excised 
fragment should have showed up as a much smaller band with a size of 266 base 
pairs. With its additional gene excised, the pOD1 vector was equal to, and will from 
now on be referred to, as pET21. 
The visible bands in figure 4.3 and 4.4 match the expected results well. Two fragments 
of expected size for pUC57_APT01 and pUC57_CPT01 are visible in figure 4.3, were 
the gene fragment of interest is marked with green boxes. This suggests that the 
digestion was successful.  In addition, a band of ~300 bp size is visible for both 
samples. This band can represent fragments made by ‘star activity’ of the restriction 
enzyme(s). Star activity represents less specific activity for restriction enzymes, 
resulting in cleavage of sequences similar but not identical to their restriction site. For 
pUC57_SLP01 it is difficult to distinguish between the two bands representing the gene 
and the vector. The large amount of DNA applied to the single well makes each band 
very strong, and considering the fact that the vector is only 706 bp longer than the 
SLP01 gene, these two fragments may overlap. For pOD1, only one band is visible 
(~5000 bp) in both figures. This could indicate that one of the restriction enzymes was 
not able to digest the DNA successfully, and that pOD1 have become linearized but 
still carries the selW gene. On the other hand, the smaller the DNA fragment, the lesser 
material there is for GelGreen to bind to. Hence, a certain number of short fragments 
will result in a weaker band compared to the same number of longer DNA fragments, 
as the longer fragments consists of more nucleotides. Some pOD1 vectors can have 
been correctly digested, without making a visible band for the selW gene fragment due 
to the low amount of DNA to detect.  
The fragments of interest, marked with green and blue boxes, were excised from the 
gel and rinsed before the DNA of the three different gene fragments was isolated and 
ligated with the pET21 plasmid, separately, to make pET21_APT01, pET21_CPT01 
and pET21_SLP01.  
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4.2.2 Transformation and verification 
To verify that correct restriction digestion and ligation took place, the pET21_gene 
plasmids were transformed into competent E. coli DH5a cells by heat shock 
transformation. The number of CFU formed after the transformation can be found in 
table 4.2. Resulting CFUs were picked and incubated O/N in LB containing ampicillin, 
and DNA was purified for each of the three gene candidates. These clones were 
checked by restriction mapping, where the DNA was digested again with BglII 
restriction enzyme for pET21_APT01 and _CPT01, and NdeI and XhoI for 
pET21_SLP01. The resulting fragments where separated using gel electrophoresis. 
The obtained fragments of this verification step can be seen in figure 4.5 and 4.6. 
Table 4.2: The number of CFU after the transformation of E. coli DH5a with pET21_gene. All negative 
controls gave zero CFU. 
Gene Culture (µl) CFU 
APT01 50 138 
200 579 
CPT01 50 51 
200 296 
SLP01 50 16 
200 25 
 
Compared to the bacterial cells transformed with APT01 and CPT01, the number of 
CFU from the transformation of SLP01 was low. This can be due to few correct 
assemblies of pET21_gene, unsuccessful enzyme digestion or ligation. SLP01 can be 
toxic to the host cell (as mentioned in section 1.3.1). If this was the case, and the pET21 
T7 promoter was ‘leaking’ and SLP01 was produced, then few correct clones would be 
able to grow. It might have been that few cells were successfully transformed, 
indicating low efficiency of competent cells. However, this is contradictory to a high 
CFU count (>>500) for the positive control in a previous transformation using cells from 
the same batch. It is also possible that the cells have lost the pET21 plasmid (e.g. due 
to metabolic strain), they will then not have been able to grow on the ampicillin 
containing agar plates.  
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Figure 4.5: Restriction mapping of 12 CFU of DH5a containing pET21_APT01 and pET21_CPT01 after 
digestion with BglII, each CFU marked with a number 1-12. The 1kb DNA Ruler from GeneScriptTM was 
run in the lanes marked ‘L’. ‘K’ represents the control plasmid, which was not cut prior to electrophoresis.   
In figure 4.5 two bands can be observed in five of the 12 samples for pET21_APT01 
(3, 4, 5, 7 and 12) and in ten of the 12 samples for pET21_CPT01 (all except 4 and 
7). Expected band sizes for correct insert of the candidate gene into the pET21 
vector is either 1523 bp for APT01 or 1535 bp for CPT01, together with 5365 bp for 
the remaining plasmid. The upper of the two bands visible (for those samples with 
two visible bands), seem to be of roughly the correct size to represent the vector, 
while the lower bands seem to contain fragments of 2000-2500 bp size, compared to 
the DNA ruler. The reason for this has not been identified. 
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Figure 4.6: Restriction mapping of 12 CFU of DH5a containing pET21_SLP01 after being cut with NdeI 
and XhoI, each CFU marked with a number 1-12. The 1kb DNA Ruler from GeneScriptTM was run in the 
lanes marked ‘L’. ‘K’ represents the control plasmid, which was not cut prior to electrophoresis.   
Correct insert of SLP01 into the pET21 plasmid was expected to give two fragments, 
one with 5365 bp and one with 2021 bp. For the control sample (K), two bands of 
5365 and 266 bp were expected. Two bands are visible in figure 4.6 for all of the 
twelve samples for pET21_SLP01, both over 2000 bp in size. Only one band, over 
5000 bp in size, is visible for the control sample. The size of fragments larger than 
3000 bp are hard to estimate, as the bands from the DNA ruler are hard to 
distinguish. However, all of the bands visible in figure 4.6 seem to be of larger sizes 
than expected for both correct and incorrect vector construction. The reason for this 
is unclear.  
As incorrect insertion of the gene would result in only one band, as seen for the 
control sample (‘K’), it was assumed that those samples that gave two bands 
represented successful cloning of the candidate gene into pET21 (for both figure 4.5 
and 4.6). Both figures showing aberrant run behaviour compared to the size 
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standard, for unknown reason. A second double digestion, using different restriction 
enzymes, could have been performed to verify correct plasmid construction.  
 
4.2.3 Purification and measurement of concentration of the new vector constructs 
When correct cloning of the candidate genes had been verified, a larger volume of 
plasmids preparation stock was prepared for recombinant protein production. The 
concentration of DNA obtained for each of the three candidates was measured using 
a NanodropTM Spectrophotometer. The plasmid measured concentrations can be seen 
in table 4.3, below.  
Table 4.3: The concentration of DNA in the samples of plasmid purifications for pET21_APT01, 
pET21_CPT01 and pET21_SLP01. 
Plasmid Concentration (ng/µl) 
pET21_APT01 43.3 
pET21_CPT01 18.1 
pET21_SLP01 51.3 
 
The obtained plasmid concentration was not high for any of the three candidates, and 
quite low for pET21_CPT01. This can indicate that the E. coli DH5α transformed with 
pET21_gene did not grow and replicate optimally, resulting in fewer cells, hence, fewer 
plasmids. Comparing with the results in table 4.2 strengthens this theory, as a much 
higher concentration of DNA was obtained from plasmid preparations from DH5α cells 
transformed with pUC57 plasmids than pOD1. As transformations using the low 
concentrated pOD1-isolate have proven successful by adjusting the amount used, and 
limitations in time for the project, it was decided to continue with the plasmid 
preparations made instead of preparing new ones to try to obtain a higher 
concentration.  
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4.3 Protein production 
The E. coli strain BL21 codon plus RIPL was chosen for expression and production of 
the gene candidates. Cells of this strain were made competent and transformed with 
the pET21_gene plasmids. An overview of obtained CFUs after transformation can be 
seen in table 4.4. 
Table 4.4: Number of CFU formed on LA plates using 50 and/or 200 µl of culture from transformed  E. 
coli BL21 cells with pET21_APT01, pET21_CPT01, pET21_SLP01, pOD1 (control), no plasmid 
(negative control) and pUC57_FragT1 (positive control).   
Plasmid Culture (µl) CFU 
pET21_APT01 50 4 
200 27 
pET21_CPT01 50 56 
200 329 
pET21_SLP01 50 25 
200 149 
pET21 50 2 
200 48 
No plasmid 50 0 
200 0 
pUC57_FragT1 200 45 
 
Adjusting the amount of plasmid preparation used based on concentration of DNA 
seemed to work, as the transformed BL21 cells with pET21_CPT01 resulted in the 
most CFU, despite the low concentration of plasmid (table 4.3). 
 
4.3.1 Protein production in 50 ml culture 
Protein production and isolation was carried out as described in sections 3.2.6 and 
3.2.7. Graphs showing the growth rates and measured absorbance for each of the cell 
cultures can be found in figure 4.7 and 4.8 (the raw data for the graphs can be found 
in appendix A.3).  
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Figure 4.7: Measured absorbance at OD600nm over time for cultures of BL21 (DE3) cells transformed 
with pET21_APT01 or pET21_CPT01, incubated at 37 °C. The points represent time and value of 
absorbance measured, while the line between the point serve as a guide for the eye. Expression of 
target gene was induced by IPTG at time 4:00, when OD600nm was close to 1, marked by the arrow.  
Figure 4.8: Measured absorbance at OD600nm over time for cultures of BL21 (DE3) cells transformed 
with pET21_SLP01 or pOD1, incubated at 37 °C. The points represent time and value of absorbance 
measured, while the line between the point serve as a guide for the eye.  Expression of target gene was 
induced by IPTG at time 4:00, when OD600nm was close to 1, marked by the arrow. 
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The growth of the E. coli BL21 transformed cell cultures in figure 4.7 and 4.8 seem to 
stabilize at en OD600nm value of 1.2-1.4. A decrease in absorbance can be observed 
for the induced cultures before their respective non-induced control cultures, for all 
candidates including the pOD1-control. This can indicate that high degree of 
expression of the target genes caused too much stress for the host cells, and they 
started to die within 3-5 hours after IPTG was added. The only exception being the 
non-induced BL21 cell culture transformed with pET21_APT01 or pOD1, which did not 
have a decrease in OD600nm when the last measurement was performed 6 hours after 
induction. 
Strain BL21 transformed with pOD1 was cultured and induced to function as a control. 
However, that was for the verification of target protein production (SDS-PAGE and 
activity assays). The induced activity of the T7 promoter in pOD1 caused over-
expression of the SelW protein in the host cells.  
Samples from pellet and supernatant of both induced and non-induced cultures for 
each of the candidates and the control were prepared and analysed by SDS-PAGE. 
The first SDS-PAGE gave results that were difficult to read, due to too much protein in 
the pellet samples and not enough in the supernatant samples (can be seen in 
appendix A2). To correct for this, TCA protein precipitation was performed on the 
supernatant samples (section 3.2.8), and a lower volume of the pellet samples was 
applied on the gel. The following results can be seen in figure 4.7 and 4.8. 
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Figure 4.9: SDS-PAGE of pellet (p) and supernatant (s) of induced (+) and non-induced (-) BL21 DE3 
codon plus cells transformed with control plasmid pOD1 (D), or pET21 plasmid carrying the gene for 
APT01 (A). Biomarker from BioRad was used (L), with sizes in kilo Dalton shown in red. The green 
box marks bands that are believed to represent the APT01 protein. “X” represents a well were no 
sample was added. 
 
Figure 4.10: SDS-PAGE of pellet (p) and supernatant (s) of induced (+) and non-induced (-) BL21 DE3 
codon plus cells transformed with control plasmid pOD1 (D), or pET21 plasmid carrying the gene for 
CPT01 (C) or SLP01 (S). Biomarker from BioRad was used (L), with sizes in kilo Dalton shown in red. 
The green box marks a band that might represent the CPT01 protein. 
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The sizes for the three peptidases are roughly 53, 57 and 73 kDa for APT01, CLP01 
and SLP01, respectively. The pellet sample from the induced pET21_APT01 
transformed cells seem to have a clearly broader band at about 53 kDa in figure 4.9 
(left in the green box), compared to the pellet sample of the non-induced APT01 cells 
and the control. The band of the same respective size is also more distinct for the 
supernatant sample of the same culture (right in the green box in figure 4.9). This 
indicates that APT01 is produced in BL21 DE3 cells following IPTG induction, although 
most of it remains in an insoluble form. A more distinct band of a size close to 57 kDa 
can be observed for the CPT01 candidate in the pellet sample of the induced cells 
(marked with a green box in figure 4.10), compared to the non-induced and control 
samples. This indicates some production of insoluble CPT01 protein. However, a 
slightly broader band of the same size can also be observed for the non-induced 
supernatant sample for CPT01. Since this sample originates from a non-induced 
culture, no CPT01 production should have taken place. As no accumulation of CPT01 
is visible for the induced supernatant sample, it is more likely that the ‘Cs-‘ well was 
contaminated with some of the induced pellet (Cp+) sample, rather than some 
production of CPT01 did occur without induction. No clear difference can be seen for 
the induced and non-induced SLP01 samples, indicating that the protein is not 
successfully produced. 
 
4.3.2 Incubation temperature at 16 °C 
One possible reason non-successful production of the three peptidases in soluble form 
can be that production at 37 °C did not allow the proteins to fold correctly relative to 
their production by the synthesis machinery. To test for this theory the cultures were 
incubated at 16 °C after IPTG was added, while all other production factors remained 
the same as the cultivation at 37 °C. As there was no visible production of SLP01 using 
the BL21 strain, the pET21_SPL01 plasmid was transformed into a different strain of 
E. coli, the ER2566 strain, which also has a T7 promoter system induced by IPTG. 
Empty vectors (pOD1 not carrying any of the three gene candidates) were also used 
to transform ER2566 cells to serve as control. Graphs showing growth rates can be 
seen in figure 4.11-4.16 (raw data can be found in appendix A.3).  
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Figure 4.11: Measured absorbance at OD600nm over time for cultures of BL21 cells transformed with 
pET21_APT01, incubated at 37 °C. After induction with IPTG at 03:50, marked by the arrow, both the 
induced (APT+) and non-induced (APT-) culture was incubated at 16 °C. The points represent time and 
value of absorbance measured, while the line between the point serve as a guide for the eye. 
Figure 4.12: Measured absorbance at OD600nm over time for cultures of BL21 cells transformed with 
pET21_CPT01, incubated at 37 °C. After induction with IPTG at 03:30, marked by the arrow, both the 
induced (CPT+) and non-induced (CPT-) culture was incubated at 16 °C. The points represent time and 
value of absorbance measured, while the line between the point serve as a guide for the eye. 
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Figure 4.13: Measured absorbance at OD600nm over time for cultures of BL21 cells (B) transformed with 
pET21_SLP01, incubated at 37 °C. After induction with IPTG at 05:30, marked by the arrow, both the 
induced (SLP+) and non-induced (SLP-) culture was incubated at 16 °C. The points represent time and 
value of absorbance measured, while the line between the point serve as a guide for the eye. 
Figure 4.15: Measured absorbance at OD600nm over time for cultures of ER2566 cells (E) transformed 
with pET21_SLP01, incubated at 37 °C. After induction with IPTG at 03:50, marked by the arrow., 
marked by the arrow, both the induced (SLP+) and non-induced (SLP-) culture was incubated at 16 °C. 
The points represent time and value of absorbance measured, while the line between the point serve 
as a guide for the eye. 
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Figure 4.14: Measured absorbance at OD600nm over time for cultures of BL21 cells (B) transformed with 
pOD1, incubated at 37 °C. After induction with IPTG at 04:50, marked by the arrow, both the induced 
(pOD1+) and non-induced (pOD1-) culture was incubated at 16 °C. The points represent time and value 
of absorbance measured, while the line between the point serve as a guide for the eye. 
 
Figure 4.16: Measured absorbance at OD600nm over time for cultures of ER2566 cells (E) transformed 
with pOD1, incubated at 37 °C. After induction with IPTG at 04:20, marked by the arrow, the culture was 
incubated at 16 °C. The points represent time and value of absorbance measured, while the line 
between the point serve as a guide for the eye. 
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A decrease in growth rate can be seen for all cultures in figures 4.11-4.16 after 
induction by IPTG. Since 37 °C is the optimal growth temperature for E. coli, this was 
an expected result when the incubation temperature was changed from 37 to 16 °C. A 
decrease in OD600nm-values was only observed for the ER2655 cultures (figure 4.15 
and 4.16). For the ER2566 culture transformed with pOD1, the absorbance started to 
decrease already 3 hours after induction, also for the non-induced control. ER2566 
has successfully been used to produce recombinant protein using T7 expression 
system and the pET21 vector in the past (Wu, 2000). Based on the data obtained in 
this experiment, it is not a successful host strain for the production of SLP01 (or SelW) 
under the conditions used. Changing one or more production parameters, such as 
temperature, medium used or concentration of IPTG added, might give improved 
results.  
No decrease in absorbance was observed for any of the BL21 strain cultures within 
the 5-7 hours where absorbance was measured after induction. Although the value 
seemed to stabilize at OD600 values of ~1.3 for the SLP01. Incubation after induction 
should have continued until the absorbance values stabilized. The reason for this not 
been done was the desire to obtain frequent absorbance measurements of the 
cultures, to avoid death of cells giving a decrease in OD600nm and a lower yield of target 
protein. However, O/N incubation at 16 °C after induction is not uncommon for 
recombinant protein production using the T7 promoter system, and considering the low 
yield of soluble target proteins obtained, it would have been a natural next step for this 
study.  
To verify production of target protein, samples from pellet and supernatant from both 
induced and non-induced cultures of the three candidates and the pOD1 control were 
analysed by SDS-PAGE, results shown in figure 4.17 and 4.18 below.   
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Figure 4.17: SDS-PAGE of pellet (p) and supernatant (s) of induced (+) and non-induced (-) BL21 DE3 
codon plus (B) and ER2566 (E) cells transformed with control plasmid pOD1 (D), or BL21 DE3 cells 
transformed with pET21_APT01(A). Incubation temperature after IPTG induction was 16 °C. Biomarker 
from BioRad was used (L), with sizes in kDa shown in red. The green box marks a band that assumingly 
represent the APT01 protein. 
 
Figure 4.18: SDS-PAGE of pellet (p) and supernatant (s) of induced (+) and non-induced (-) BL21 DE3 
codon plus (B) and ER2566 (E) cells transformed with control plasmid pOD1 (D) or pET21_SLP01, or 
BL21 DE3 cells transformed with pET21_CPT01 (C) or pET21_SLP01 (S). Incubation temperature after 
IPTG induction was 16 °C. Biomarker from BioRad was used (L), with sizes in kDa shown in red.  
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The analysis of pellet samples in figure 4.17 and 4.18 are difficult to interpret due to 
too much protein present. To get clearer results, new samples were prepared from 
pellet and supernatant from the induced cultures, where the centrifugation time was 
increased to remove contamination, and a smaller volume of the pellet samples was 
applied on the gel. The results from this gel can be seen in figure 4.19. 
Again, it can be observed that pET21_APT01 transformed cells produced the APT01 
protein after induction with IPTG, and that most of the protein was present as an 
insoluble form in the pellet (marked with a green box in figure 4.17 and blue boxes in 
figure 4.19). A distinct band from a probable CPT01 production can also be observed 
at about 57 kDa for the induced pellet sample of pET21_CPT01 carrying cell culture 
(marked with a green box in figure 4.19), as in the 37 °C incubation results from figure 
4.10. But this time, no broader band can be seen in figure 4.19 for the non-induced 
supernatant sample of CPT01, reinforcing the theory that the respective sample in 
figure 4.8 was contaminated. A band matching the size of that, assumingly, produced 
by the APT01 protein, can be observed in the supernatant sample of the induced 
Figure 4.19: SDS-PAGE of pellet (p) and supernatant (s) of induced (+)BL21 DE3 codon plus (B) and 
ER2566 (E) cells transformed with control plasmid pOD1 (D) or pET21_SLP01, or BL21 DE3 cells 
transformed with pET21_APT01 (A), pET21_CPT01 (C) or pET21_SLP01 (S). Biomarker from BioRad 
was used (L), with sizes in kilo Dalton shown in red. The blue and green boxes marks a band that 
assumingly represent the APT01 and CPT01 protein, respectively. The orange box marks a band equal 
to that of ATP01 indicating contamination between wells. 
 
Results and discussion 
55 
 
control (pOD1), marked with an orange box in figure 4.19. The control plasmid pOD1 
does not carry the APT01 gene, but selW, encoding a selenoprotein of about 9.8 kDa 
size. Therefore, the presence of a distinct band of this size in the control sample cannot 
be used for the verification of a potential APT01 production. However, this band is not 
visible for the same sample in figure 4.9, which suggests that this sample in figure 4.19 
was contaminated from the neighbouring well containing the APT01 protein. No bands 
indicating a production of the SLP01 protein can be observed, for either the E. coli 
BL21 (DE3) or the ER2566 cell cultures in figures 4.18 and 4.19. 
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4.3.3 Heat denaturation series 
One of the assumed features of the chosen protein candidates were that, if they were 
successfully produced, they would be stable at high temperatures due to adaptations 
to the environment in the deep subsurface oil reservoirs. The APT01 peptidase 
seemed to be the only candidate that was produced in soluble form (figure 4.17 and 
4.19), and was therefore the only candidate tested for heat stability. Two heat 
denaturation series were performed on samples from the supernatant of induced 
pET21_APT01 cultures (section 4.3.2). Samples were kept on heat blocks with 
different temperatures for different duration. Figure 4.13 shows the SDS-PAGE results 
of the heat denaturation. 
Several bands can be observed for all samples subjected to 65 °C, while the amount 
of visible bands observed for samples 7-10 drastically diminishes. Only one clearly 
distinct band is present for samples subjected to 80 °C, and this seem to represent a 
protein with the size of ~40 kDa. This band might be produced by one of the 
Figure 4.20: SDS-PAGE of 11 samples from supernatant of cell cultures of E. coli BL21 cells 
transformed with pET21_APT01, induced with IPTG and incubated at 16 °C. Sample 1-5, where ATP01  
is marked with a green box, was subjected to 65 °C for 5, 15, 30, 60 and 120 minutes, respectively. 
Sample 6-10, ATP01 marked with a blue box, was subjected to 80 °C in the same order. ‘K’ represents 
a sample of supernatant not subjected to any heat prior to SDS preparation (APT01 marked with a 
yellow box). Biomarker from BioRad was used (L), with sizes in kDa shown in red. 
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components in the DnaK chaperone system, consisting of the heat shock proteins 
DnaK, DnaJ and GrpE (Schönfeld, 1995). 
A band assumingly representing presence of ATP01 is visible in all of the samples 
subjected to 65 °C (sample 1-5), marked with a green box in figure 4.13. The band 
seems to become more diffuse as the duration of heat exposure increases, indicating 
that the amount of the APT01 protein denatured was increased when subjected to 
65 °C for a longer time. However, not much difference can be seen for the APT01-band 
of sample 3-5, suggesting that there were some proteins present that were stable at 
65 °C. For the 80 °C heat series, hardly any APT01 can be observed in the blue box 
for sample 7-10 in figure 4.13. From these results, it would seem like some the soluble 
APT01 produced by the E. coli BL21 cells are stable at 65 °C, but not at 80 °C.  
Plausible reasons for the obtained target protein of APT01 not being heat stable, can 
be incorrect post-translational modifications of the enzyme, lack of necessary co-
factors or heat-stability chaperones. The structures of heat stable proteins do not 
necessarily differ much from those of less thermostable proteins (Kumar, 2000). Any 
factor influencing on the structure of a protein, such as pH, co-factors and pressure 
(discussed further below), can therefore affect the thermostability. 
Heat denaturation can be used to purify thermostable target enzymes produced by 
recombinant gene technology, as most of the other proteins produced by mesophiles, 
such as E. coli, will denature at temperatures above 40 °C. However, as can be seen 
in figure 4.20, there are still several bands representing other proteins present in the 
sample after heat denaturation at 65 °C, and purification using 80 °C will not be 
successful since the target enzyme does not seem to be stable at this temperature. A 
possible next step for this study could be to test for heat stability for temperatures 
between 65-80 °C, and to what degree that purifies the samples.   
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4.3.4 Protein production in 1L cultures 
There are several ways of increasing the probability for production of soluble proteins 
from recombinant expression. Lowering the incubation temperature did not improve 
the yield of the target proteins (section 4.3.2). A different theory for unsuccessful 
recombinant protein production is that the protein of interest is produced at such a low 
concentration in the cell that it makes it difficult to detect presence and activity without 
purification of the protein. As the His-tag modification was unsuccessful and the protein 
obtained was not heat stable, purification of the proteins of interest would require 
alternative approaches, which there were not time for at this stage. Instead, an 
up-scaling of the cultivation was performed as a last attempt to produce the peptidase 
candidates in soluble form.  
The overnight inoculum was added to 1 litre of medium, and IPTG was added for 
induction when absorbance measures equalled ~3. Due to a limited number of 
Erlenmeyer flasks large enough for 1 litre cultures, the cultures were not divided to give 
a non-induced control. The cells transformed with pOD1 was therefore the only control 
sample for comparisons, for this round of protein production. As there had been no 
visible production of SLP01 previously, this candidate was not included in the 
up-scaled cultivation (also due to limited equipment). After induction, the cultures were 
incubated at 16 °C for five hours. As for the previous rounds, a frequent measure of 
absorbance was desired, so the time for incubation was determined by previous 
cultivation results. 
As an attempt to time the experiment so that the three cultures reach an OD value of 
about 3, and hence could be induced at the same time, the pOD1-culture was 
inoculated an hour earlier than the two others (APT01 and CPT01). This decision was 
based on the results from earlier in this study showing that the BL21 cells transformed 
with pOD1 had a slower growth compared to those transformed with pET21_APT01 or 
pEt21_CPT01 (figure 4.12-4.14 and appendix A.3). However, for this experiment the 
pOD1-containing cells grew rapidly reaching OD of 3 much earlier than the other two. 
The flask was therefore taken out of the shaking incubator at time 05:00, and kept at 
room temperature (without shaking) until the other two cultures reached the desired 
cell density. Induction was performed at the same time for all three cultures (at time 
04:45 for APT and CPT, and 05:45 for pOD). After IPTG was added, all three cultures 
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where incubated at 16 °C in a shaking incubator. Measured OD values are displayed 
as graphs in figures 4.21, 4.22 and 4.23.  
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Figure 4.21: Measured absorbance at OD600nm over time for cultures of BL21 cells transformed with 
pET21_APT01 (APT) or pET21_CPT01 (CPT), incubated at 37 °C. After induction with IPTG at 04:45, 
marked by the arrow, the cultures were incubated at 16 °C. The points represent time and value of 
absorbance measured, while the line between the point serve as a guide for the eye. 
Figure 4.22: Measured absorbance at OD600nm over time for cultures of BL21 cells transformed with 
pOD1 (pOD), incubated at 37 °C. After induction with IPTG at 05:45, marked by the arrow, the culture 
was incubated at 16 °C. The points represent time and value of absorbance measured, while the line 
between the point serve as a guide for the eye. 
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The growth rate seemed to decrease, as expected (section 4.3.2), for all three parallels 
after the incubation temperature was changed from 37 to 16 °C. A steady, continuous 
increase in the absorbance values can be observed for the CPT01-culture from time 
06:50-09:45, while the cells transformed with pET21_APT01 seem to stabilize at an 
OD-value of about 6.5, before increasing at time 09:45.  
As previous, both samples from the pellet and supernatant of the lysed cells were 
analysed using SDS-PAGE. The results from the separation of the proteins produced 
can be seen in figure 4.23. 
 
 
Figure 4.23: SDS-PAGE of pellet (p) and supernatant (s) of induced (+) BL21 DE3 codon plus cells 
transformed with control plasmid pOD1 (D), pET21_APT01 (A), or pET21_CPT01 (C). Incubation 
temperature after IPTG induction was 16 °C. Biomarker from BioRad was used (L), with sizes in kilo 
Dalton shown in red. The blue and green box marks the band assumingly representing the APT01 and 
CPT01 protein, respectively.  
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After this round of recombinant protein production, the amount produced of the protein 
of interest in insoluble form seemed to be much more for CPT01 compared to APT01, 
indicated by the width and intensity of the bands marked with the green and blue box, 
respectively. The supernatant samples from the upscaled cultivation contained a lot of 
protein and resulted in many bands on SDS-PAGE gel, causing the bands to become 
undefined and difficult to interpret. Figure 4.23 shows an image of the gel where the 
supernatant samples were centrifuged for a prolonged time and a low volume were 
applied on the gel. Still, it is hard to distinguish between the different bands for the 
supernatant samples. However, there does not seem to be a band for APT01 or CPT01 
from the supernatant samples, indicating that what was produced of these proteins 
remained insoluble.  
Compared to previous results (figure 4.9, 4.17 and 4.19), the amount of APT01 relative 
to the other proteins in the same sample appear to be much less. Reasons for this can 
be that conditions for 100 ml cultivation is favoured over that of 1 L, for this candidate. 
As mentioned above, three times the concentration of tryptone and yeast extract was 
used in the 1 L culture medium, to compensate for demand for a higher OD value. 
During incubation the intensity of the shaking was adjusted to 180 rpm for the 1 L 
cultures, compared to 225 rpm for the 50/100 ml cultures. This, along with the size of 
the Erlenmeyer flasks and how much of the total volume of the flask is filled with 
medium, affects the formation of foam and accessibility of oxygen to the cells. 
Apparently, these conditions were favoured for production of CPT01 in 1 L cultures, 
and APT01 in 50/100 ml cultures. However, the 1 L conditions did not seem to favour 
soluble production of these proteins, for either of the two candidates.  
Due to the continuous increase in growth rate, a longer incubation period could have 
been used to obtain a higher yield of protein, and perhaps also in soluble form as 
necessary post-translational modifications of the enzymes might have needed more 
time to be performed.  
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4.3.5 Activity assay using skim milk agar  
Single CFUs from transformed BL21 cells were streaked on milk agar plates containing 
ampicillin and IPTG to test if active peptidases were secreted from the cells. 
Proteinase K was also applied on the plate, as a positive control. No activity, except 
for the positive control, could be observed on these plates after 24 and 48 hours 
incubation at 37 °C, 45 °C or 60 °C.  
All induced supernatant samples from the protein production using 50 ml and 1 litre 
cultures and 16 °C incubation temperature (after induction), were tested on MA plates, 
along with the induced control vector (pOD1) as a negative control and the positive 
control proteinase K. After both 24 hours and 48 hours incubation at 37 °C, only the 
positive control produced a clearing on the plate, as seen in figure 4.24. This suggests 
that no active peptidase was produced in soluble form for the cells transformed with 
pET21_APT01, pET21_CPT01 or pET21_SLP01. 
Figure 4.24: MA plate with  drops of induced supernatant samples from the protein production attempt 
that used cultures of 1 litre and incubation temperature was set to 16 °C. ‘APT’,’ CPT’ and ‘pOD1’ 
represents the quadrant where sample was added from the cell cultures transformed with 
pET21_APT01, pET21_CPT01 and pOD1, respectively. ‘P.K’ marks the quadrant where the positive 
control was added. 
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To observe activity on the MA plates was not expected for the samples for CPT01 or 
SLP01, as no production of the proteins had been identified in the supernatant samples 
from the induced cultures. The hopeful candidate for this activity assay was the 
supernatant sample containing soluble APT01, seen in figure 4.17 and 4.19. However, 
no ‘halo’ was made by the APT01 from this sample. Possible explanations for this are 
many, as it is not known whether this enzyme requires co-factors or chaperones not 
present in E. coli in order to function as intended. The activity of this enzyme may also 
be dependent on high temperature and/or pressure.  
The in situ temperatures of the two oil wells sampled to make the metagenomic DNA 
library used for this project, are 86 and 83 °C for well I and II, respectively (Lewin, 
2013). In other words, the putative enzymes identified and produced have adapted to 
this temperature, and the optimum temperature for activity is probably around 80 °C. 
A possible solution for the negative result on the MA plates can be that the activity at 
temperatures far below the enzymes optimum temperature is so low that this activity 
assay in not sensitive enough to detect the hydrolysis performed by the target proteins. 
 
Reasons why the production of the target enzymes in a soluble form was not 
successful are numerous. The most probable reason is that, as a host organism 
expressing the target gene in a completely different environment than that of a deep 
subseafloor oil reservoir, E. coli and the surrounding environment does not contain the 
correct factors for successful production of the recombinant protein. Although the type 
of organisms who’s DNA have been expressed successfully in E. coli is diverse, 
heterologous expression is still one of the main challenges within metagenomic 
research (Handelsman, 2004, Streit, 2004). The presence of components needed for 
post-translational modification of recombinant proteins are difficult to predict, and even 
more complex than the expression mechanisms. A study done by Gabor and 
colleagues (2004) showed that of the genes from 32 prokaryotic genomes, only 40 % 
could be detected when expressed in E. coli. E. coli is commonly used for heterologous 
protein production because of its strengths as a well-studied, cheap and easy-to-grow 
organism, however development of novel experimental systems for expression of 
metagenomic genes are needed. 
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The DNA sequences selected as gene candidates in this study are putative genes. 
Although, measures were made to increase the chance of identifying a functional gene, 
that might not have been successful. The sequences identified can represent so-called 
pseudogenes, sequences that have been a functional gene once, but are no longer 
expressed in the cell, often due to accumulation of mutations. Most pseudogenes have 
gene-like features, such as promoters, and can be perceived as a functional gene 
when just looking at the DNA sequence. 
It has been shown that high pressure has a significant effect on both stability and 
activity of various proteins, including several peptidases (Eisenmenger, 2009). For 
instance, the activity of the serine peptidase α-Chymotrypsin was 30 times higher at 
50 °C and 360 MPa, compared to at 20 °C and 0.1 MPa. While the stability of the same 
enzyme was increased, from less than five minutes half-life to being active for 30 
minutes, when the pressure was increased from 0.1-180 MPa at 52.5 °C (Mozhaev, 
1996). Also, the reaction rate of a thermostable peptidase, thermolysin (from Bacillus 
thermoproteolyticus), increased by more than 13 times when subjected to pressure of 
100 MPa (Fukuda, 1984). Considering that the putative genes used for this project 
originate from organisms living in an environment with pressure values of 250 bar (25 
MPa), it is plausible that both their activity and stability has decreased when being 
expressed at atmospheric pressure (1 bar), which would make it more difficult to 
produce the target peptidases in soluble, functional form. 
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4.4 Future work 
Based on the results obtained from this study, further work should investigate the use 
of different expression systems in order to get production of more soluble target protein 
from the candidate genes chosen for functional testing and characterization. Using a 
host organism with similar codon usage is one optimisation possibility. The use of 
thermophiles as host organisms can be applicable, as recent studies have shown that 
inducible gene expression systems in such strains have been used successfully 
(Suzuki, 2013).  
The possibility of solubilizing and refolding of the target protein observed in the pellet 
samples should also be investigated. Solubilization is normally done using chemical 
denaturants. However, there is no universal method for refolding proteins, and the 
recovering yield is usually low. Continuous development of new methods, such as 
oxidative column chromatography, will improve the number of proteins that can be 
refolded (Middelberg, 2002). 
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5. CONCLUSION 
In this study, three putative genes for novel peptidases were identified from a 
metagenomic DNA library constructed from total DNA of samples from two deep 
subsea oil reservoirs on the Norwegian Continental Shelf. Each of these sequences 
showed high degree of homology to a known peptidase of sub-classification 
subtilisin-like serine peptidases, aminopeptidases or carboxypeptidases. Hence, given 
the abbreviations SLP01, APT01 and CPT01. 
The T7 promoter expression system was used for protein production of the 
recombinant proteins in Escherichia coli strains BL21 (DE3) CodonPlus-RIPL and 
ER2566, using the plasmid vector pET21. Several attempts for protein production were 
performed, using culture volumes of 100 ml or 1 litre and temperatures 16 or 37 °C for 
incubation after induction of target gene expression with IPTG. Desired protein 
production was verified using SDS-PAGE analysis. Visible target protein was observed 
for the APT01 and CPT01 candidate produced by the BL21 strain, although in an 
insoluble form. Some soluble APT01 was observed from the 100 ml culture of BL21 
cells, incubated at 16 °C. No visible production of the target protein for the SLP01 
candidate could be observed for any of the production attempts. 
Heat denaturation series was performed on the sample containing soluble APT01, at 
temperatures of 65 and 80 °C for a duration of 5, 15, 30, 60 and 120 minutes. The 
results showed APT01 to be thermostable at 65 °C, but none at 80 °C.  
An activity assay, using skim milk agar (MA) plates, was performed on all samples from 
the protein production. No activity was observed for any of the three candidates. 
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APPENDIX A.1 – Gene sequences 
 
CA▼TATG = NdeI restriction site, ATG = START codon 
A▼GATCT = BglII restriction site 
T▼GATCA = BclI restriction site, TGA = STOP codon 
CATx6 = His-tag 
TAA = STOP codon 
C▼TCGAG = XhoI restriction site 
CCAAT/CAAT, ATTGG = Protective bases 
 
Aminopeptidase - APT01  
CCAATCA▼TATGCGTATCGCCGTGGACTTTAGCCCGCCGCTGACCCTGAAAACCTCGTGTCTGGTGCT
GGGTGTGTGGCAAGATCGTACCAAAACGCAGCTGCTGAAAGACCTGGATGACAGCCTGCATGGTGCCC
TGCGTCTGTCAGTTGACTCGGGCGCATTTTCTGGCAAACAAGGTGAAACCCAGCTGTTCCAAGCTGGT
GCGGGTGTCCCGGCAGCACGTATTCTGCTGGTTGGCCTGGGTCCGTTTGAAGCAGCTGATGCAGACGT
TCTGCGTCGCGGTGCAGCAGAAGCAGCTCGTGTTCTGCAGAAACAACACGTCGGCGAAGCCGGTATGG
TGTGCCCGGAATCACCGGCACGTCTGAACCCGGCTCAGGTGGCACAAGCACTGGCTGAAGGCCTGCTG
CTGGCGTCGTATCGTTTCGATCGCTACCTGACGCAGAAACGTGAAGAACTGCCGCCGCTGCTGGAAAA
TGTGGTTATTCTGGCGGCCCAAGAACATGTGGAATCCCTGGCAGCTGCGGTTGATCGTGCACGCCTGA
TCTGCCGTGGTGTGTCACTGGCGCGCGACCTGGTTAACGAACCGGGCAATGTCAAATCGCCGGAATTT
CTGGCGGAACAGGCCCGTAAAATGGCCGCACGCCACAACATTGTGTGTACCGTTCTGGAACGCGATCA
GCTGGAAAAAGAAGGCTTCGGTGCACTGCTGGCAGTTGCACAAGGTAGCGCACGTCCGCCGCGTCTGA
TTGTCCTGGAATATCGTGGCGGTGAACCGCAGGAACGTCCGGTCGCGCTGGTTGGCAAAGGTGTCGTG
TTTGACAGCGGCGGTATCTCTCTGAAACCGGGCGAAAAAATGGATGAAATGAAAATGGACATGGCAGG
CGCTGCGGCCGTTATTGGTGCTATGGAAGCAGCTGCGGGTCTGCGTCTGCCGGTTAACCTGGTCGGCA
TCGTGCCGGCGGTTGAAAATCTGCCGAGCGCAACCGCTTATCGCCCGGGTGATATTATCACCAGTCTG
TCCGGCCAGACGATTGAAGTGCTGAATACCGATGCGGAAGGTCGTCTGATCCTGGCAGACGCACTGAC
GTACGCGGGTCGTATGGAACCGCGTACCGTGATTGATCTGGCCACCCTGACGGGCGCGTGCATTATCG
CCCTGGGTCATGAAGCAAGTGCTGTTTTCTCCAACCACGACGAACTGGCGCGTAATCTGATGCGCGCC
GGCGAAAGCTCTGGTGAACGCCTGTGGCAGCTGCCGCTGTGGGAAAACTATGGTAAACAACTGAAAAG
TGAAGTCGCCGATGTGAAAAATACGGGCGGTCGTCCGGCAGGTACCATTACGGCCGCATCCTTTCTGC
AGCGTTTCGCACCGGAAGGTCCGTGGGCTCATGTCGATATCGCAGGCACGGCTTGGGAAGACAAAGGT
ACCGCACTGTGTCCGAAAGGTGCAACCGGCGTTGGTGTCCGTATGCTGATCGATTACCTGGAACAGGT
GA ▼GATCTT▼GATCACATCATCATCATCATCATTAAC▼TCGAGATTGG (1540bp) 
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Carboxypeptidase - CPT01 
CAATCA▼TATGGATGCTCTGGAAAAACTGAAAGCTCTGTCGAAAGAACTGGAACTGATTAACGCCGCC
GTCGCTACGATGGCCTGGGACCAACGCACCTATATGCCGCCGAAATCAGCAGGCACGCGTTCGGAAGC
TATTGGTTACCTGAGCACCATCGCATTCAAAAAATTCATCTCTGATGAAACGGGCGAAATTATCCGTG
AACTGGAAAAAGAAGATAACTTTAATCGCCTGGACGAAAATGAAAAAGCGATGGTGCGTATTGCCAAA
CGCGAATATGAAAAAGCAAAAGCTATCCCGCCGGAACTGTTTCAGAAATTCACCATTACGGCGAGCAA
ATCTGAAACCGTTTGGGAACAGGCGAAGAAAAACAACGATTTCAAAAGTTTCCAACCGTATCTGGAAG
AACTGCTGGAAATGCTGCGCGAAATGGCGGAACTGTATGGCTACAAAGAAAACCCGTATGATGCCCTG
CTGGACAAATACGAACCGGGTATCACCACGCGTAAACTGAAGAAAATTATCGAAACCCTGAAAGCGGA
ACTGATTCCGTTTCTGCGCGAAATTATCGAACAGAAAGGTAAAACGGATCCGTCAATCCTGTATGGCC
GTTTCGGTAAAAAAGCCCAAGAAAAACTGTCGATCCGCGCACTGAAAGCTATTGGCTACGATTTTGAA
GCAGGTCGTCTGGACGAAACCGTGCATCCGTTCACGATTAGTCTGGGCGCTGGTGATGTGCGCGTTAC
CACGAAATATGACCCGCACTTTCTGCAGCCGTCCCTGTACGGCACCTTCCATGAAGGCGGTCACGCGC
TGTATGAACAAGGTCTGCCGGAAGAATTTAAATATACCCCGATCTACGGCGCCGTTAGCCTGGGTATT
CATGAAAGTCAGTCCCGTATGATGGAAAATATGGTCGCACGCTCTTATGAATTCCTGAAATTTTTCTA
CCCGGAAATCAAAAAAGTGTTTCCGAAACAATTCGGCCGTGTTAGTCTGGATCGTTTCTATCGCGCAA
TCAATCATGTCGAACCGTCCCTGATTCGTATCGAAGCTGACGAAGTGACCTACAACTTTCACATTATG
CTGCGCTTCGAACTGGAAGAAGCGATGCTGAACAAATCTCTGGAAGTTAAAGACCTGCCGCGTGCGTG
GAACGAAAAAATCAAAGAATACCTGGGCATCGAACCGCAGAACGATGCAGAAGGTGTTCTGCAAGACG
TCCACTGGGCTAATGGCATGATTGGTTATTTTCCGAGCTACATGCTGGGCAACCTGTACGCGGCCCAG
CTGTTCGCGAAAGCCGAAGAAGAAATCCCGAAACTGCGTAAAAACATCGAAAAGGGTAACGTCGCGGT
GCTGATCGAATGGCTGCGTGAAAATATTCATCGCCACGGCAAAAAATATCTGCCGGAAGAACTGATTA
AAATCAGCACCGGTGAAGAACTGAACCCGGAATATTTTATTCGCTACATCAAAGAAAAATATACGAAA
ATTTACGAAATCA ▼GATCTT▼GATCACATCATCATCATCATCATTAAC▼TCGAGATTGG 
(1551bp) 
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Subtilisin-like peptidase - SLP01 
CCAATC▼ATATGCGTAAAGTTCTGGGTCTGCTGGTCGCGTTTCTGATGCTGGGTTTCGTTGTCGCTTC
GGTCGCCGCTCTGCCGTCCCCGGATACCAAACCGTATACCCAGCCGAAAAACTACGGCCTGCTGACGC
CGGGTCTGTTTCGTAAAGCACAGCGCATGGATTGGGAACAAGAAGTGAGCACCATTATCATGTTCGAC
ACGCCGCGTAATCAGCGCATCGCGCTGAAAATTCTGAAAGCTCTGGGCGCGGAAGTGAAATATCAATA
CGAAGTTATTCCGGCCATCGCAGTGAAAATGAAAGTTCGTGATCTGCTGGTTATTGCGGGCTTTCTGG
ACGCCACCAGCTCTGGTCGCAGTAAAGTCCAGATTCCGGGCATCCAGTTCATCCAAGAAGATTACAAA
GTCAAAGTGGCCGTTGAAACCGAAGGCCTGGACGAATCCGCGGCCCAAGTGATGGCAACCAACATGTG
GAATCTGGGTTATGATGGTTCAGGCATTACCATCGGCATTATCGATACGGGTATCGACGCGTCGCATC
CGGATCTGCAGGGTAAAGTTATTGGCTGGGTTGACTATGTCAACGGCCGTAGTTCCCCGTACGATGAC
AATGGTCATGGCACCCACGTGGCAAGCATTGCAGCTGGTACGGGTGCAGCCTCTAACGGTAAATATAA
AGGCATGGCCCCGGGTGCAAAACTGGTCGGCATCAAAGTGCTGGGTGCAGATGGTAGCGGCTCTATTA
GTGATATTATCGCAGGTGTTGACTGGGCTGTCAAAAACAAAGATAAATACGGCATCAAAGTTATTAAT
CTGAGCCTGGGCTCATCGCAGAGCTCTGATGGTACCGACTCCCTGTCACAAGCCGTGAACAATGCTTG
GGATGCGGGTCTGGTGGTTTGCGTTGCAGCTGGTAACTCTGGCCCGAATAAATATACCGTCGGTAGCC
CGGCGGCCGCATCTAAAGTGATTACCGTTGGCGCGGTCGATAAATACGACGTGATTACCGATTTTAGT
TCCCGTGGCCCGACGGCAGACAACCGTCTGAAACCGGAAGTCGTGGCTCCGGGTAATTGGATTATCGC
TGCGCGTGCGTCAGGTACCTCGATGGGTCAGCCGATCAATGATTATTACACGGCAGCACCGGGTACCA
GCATGGCAACGCCGCATGTTGCAGGTATTGCTGCACTGCTGCTGCAGGCACACCCGTCTTGGACCCCG
GATAAAGTTAAACGTGCACTGATCGAAACGGCTGACATTGTCAAACCGGATGAAATCGCCGACATTGC
GTATGGCGCTGGCCGCGTGAACGCGTACAAAGCCGCATATTACGATAATTATGCGAAACTGACCTTTA
CGGGCTACGTTGCCAACAAAGGTTCACAGACCCATCAATTTACGATCTCGGGTGCAGGTTTCGTGACC
GCAACGCTGTATTGGGATAATTCGGGTAGCGATATTGACCTGTATCTGTACGATCCGAACGGCAATCA
GGTCGACTATAGTTACACCGCGTATTACGGCTTCGAAAAAGTGGGTTATTACAACCCGGCTGCGGGTA
CCTGGACGATCAAAGTTGTCTCTTATAGTGGCTCCGCTAACTACCAGGTTAATGTGGTTAGCGATGGT
ACCCTGGGTCAACCGGGCGGTGGCGAACCGGCACCGGAACCGACCCCGGAACCGACGGTCGATGAAAA
AACCTTTACGGGCACCGTGCACCGTTATTACGATCGCAGTGACACGTTCACCATGACGGTGAATTCCG
GCGCGACCAAAATTACGGGTGATCTGACCTTTGACACGGGTTATCATGATCTGGACCTGTACCTGTAT
GATCCGAACAAAAATCTGGTGGACCGTAGTGAATCATCGAACTCCTATGAACACGTTGAATACACCAA
TCCGGCGCCGGGCACGTGGTATTTCCTGGTGTACGCATATTACACCTATGGCTACGCTAGCTATCAGC
TGGATGTCAAAGTGTATTACGGTA ▼GATCTT▼GATCACATCATCATCATCATCATTAAC▼TCGAGAT 
TGG (2038bp) 
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APPENDIX A.2 – SDS-PAGE result
Figure A.2.2: SDS-PAGE of pellet (p) and supernatant (s) of induced (+) and non-induced (-) BL21 DE3 
codon plus cells transformed with control plasmid pOD1 (D), or pET21 plasmid carrying the gene for 
CPT01 (C) or SLP01 (S). Biomarker from BioRad was used (L), with sizes in kilo Dalton shown in red.  
 
Figure A.2.1: SDS-PAGE of pellet (p) and supernatant (s) of induced (+) and non-induced (-) BL21 DE3 
codon plus cells transformed with control plasmid pOD1 (D), or pET21 plasmid carrying the gene for 
APT01 (A). Biomarker from BioRad was used (L), with sizes in kilo Dalton shown in red.  
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APPENDIX A.3 – OD600nm values 
 
Table A.3.1: Absorbance measurements for protein production at 37 °C, using 50/100 ml culture 
(section 4.3.1), for induced (+) and non-induced (-) BL21 cells transformed with pET21_APT01 or 
pET21_CPT01. 
Time (tt:mm) APT+ (OD600nm) APT- (OD600nm) CPT+ (OD600nm) CPT- (OD600nm) 
00:00 0,025 0,023 
01:00 0,05 0,056 
03:10 0,873 0,91 
04:00 1,087 1,058 1,048 1,055 
05:00 1,319 1,47 1,532 1,48 
06:00 1,481 1,661 1,699 1,647 
07:05 1,533 1,679 1,556 1,687 
07:40 1,655 1,797 - 1,802 
08:50 1,516 1,81 - 1,802 
09:00 - 1,825 - - 
09:20 - 1,839 - - 
09:40 - 1,851 - - 
 
Table A.3.2: Absorbance measurements for protein production at 37 °C, using 50/100 ml culture 
(section 4.3.1), for induced (+) and non-induced (-) BL21 cells transformed with pET21_SLP01 or pOD1. 
Time SLP+ (OD600nm) SLP- (OD600nm) pOD+ (OD600nm) pOD- (OD600nm) 
00:00 0,017 0,021 
01:00 0,038 0,046 
03:10 0,554 0,708 
04:00 0,875 0,928 0,957 
05:00 1,387 1,398 1,292 1,433 
06:00 1,539 1,604 1,371 1,618 
07:05 1,393 1,617 1,404 1,705 
07:25 - 1,721 1,463 1,774 
08:05 - 1,702 1,483 1,808 
08:50 - - 1,471 1,817 
09:20 - - - 1,826 
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Table A.3.3: Absorbance measurements for protein production at 16 °C, using 50/100 ml culture 
(section 4.3.2), for induced (+) and non-induced (-) BL21 cells transformed with pET21_APT01. 
Time APT+ (OD600nm) APT- (OD600nm) 
00:00 0,043 
01:30 0,078 
03:00 0,581 
03:30 0,985 
04:50 1,011 1,020 
05:50 1,047 1,093 
06:50 1,163 1,140 
07:50 1,189 1,170 
08:50 1,215 1,231 
09:50 1,271 1,291 
10:50 1,326 1,335 
 
Table A.3.4: Absorbance measurements for protein production at 16 °C, using 50/100 ml culture 
(section 4.3.2), for induced (+) and non-induced (-) BL21 cells transformed with pET21_CPT01. 
Time CPT+ (OD600nm) CPT- (OD600nm) 
00:00 0,023 
01:30 0,115 
03:00 0,775 
03:20 0,919 
04:30 1,045 0,999 
05:30 1,112 1,080 
06:30 1,142 1,160 
07:30 1,196 1,190 
08:30 1,217 1,202 
09:30 1,247 1,242 
10:30 1,314 1,272 
 
Table A.3.5: Absorbance measurements for protein production at 16 °C, using 50/100 ml culture 
(section 4.3.2), for induced (+) and non-induced (-) BL21 cells transformed with pET21_SLP01. 
Time (B)SLP+ (OD600nm) (B)SLP- (OD600nm) 
00:00 0,034 
01:30 0,033 
03:00 0,131 
03:50 0,360 
05:20 1,137 
06:30 1,154 1,156 
07:30 1,192 1,203 
08:30 1,225 1,216 
09:30 1,260 1,274 
10:30 1,301 1,32 
11:10 1,313 1,323 
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Table A.3.6: Absorbance measurements for protein production at 16 °C, using 50/100 ml culture 
(section 4.3.2), for induced (+) and non-induced (-) BL21 cells transformed with pOD1. 
Time (B)pOD1+ (OD600nm) (B)pOD1- (OD600nm) 
00:00 0,029 
01:30 0,031 
03:00 0,177 
03:30 0,541 
04:50 1,047 
06:50 1,154 1,133 
07:50 1,166 1,181 
08:50 1,212 1,211 
09:50 1,244 1,263 
10:50 1,304 1,308 
 
Table A.3.7: Absorbance measurements for protein production at 16 °C, using 50/100 ml culture 
(section 4.3.2), for induced (+) and non-induced (-) ER2566 cells transformed with pET21_SLP01. 
Time (E)SLP+ (OD600nm) (E)SLP- (OD600nm) 
00:00 0,019 
01:30 0,078 
03:00 0,593 
03:30 0,926 
04:50 0,996 1,021 
05:50 1,041 1,021 
06:50 1,057 1,082 
07:50 1,123 1,11 
08:50 1,105 1,131 
 
Table A.3.8: Absorbance measurements for protein production at 16 °C, using 50/100 ml culture 
(section 4.3.2), for induced (+) and non-induced (-) ER2566 cells transformed with pOD1. 
Time (E)pOD1+ (OD600nm) (E)pOD1- (OD600nm) 
00:00 0,018 
01:30 0,051 
03:00 0,274 
03:50 0,815 
04:15 0,949 
05:20 0,998 1,027 
05:50 1,111 1,086 
07:20 1,089 1,081 
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Table A.3.8: Absorbance measurements for protein production at 16 °C, using 1 litre culture 
(section 4.3.4), for induced (+) and non-induced (-) BL21 cells transformed with pET21_APT01, 
pET21_CPT01 or pOD1. 
 
Time 
OD600nm  
Time 
OD600nm  
pOD1 APT01 CPT01 IPTG induced 
(yes/no) 
00:00 0,1085 00:00 0,1112 0,1115 N 
01:00 0,1111 01:00 0,1182 0,1158 N 
02:00 0,1380 02:00 0,1868 0,1326 N 
03:00 0,2992 03:00 1,1065 0,5235 N 
04:00 1,6570 03:30 2,1800 - N 
04:30 3,1570 04:00 2,9190 1,3960 N 
05:00 4,0760 04:35 4,7940 2,2080 N 
06:45 6,5060 05:45 6,4220 4,1680 Y 
07:50 6,3160 06:50 6,6240 4,7420 Y 
08:45 6,7960 07:45 6,5180 4,9140 Y 
09:45 7,3340 08:45 6,4380 5,0040 Y 
10:45 7,5020 09:45 6,7460 5,3580 Y 
 
 
 
 
 
 
 
